Coronaviruses	coronaviruse	NNS	O
are	be	VBP	O
single	single	RB	O
-	-	HYPH	O
stranded	strand	VBN	O
RNA	RNA	NNP	O
viruses	virus	NNS	O
with	with	IN	O
large	large	JJ	O
,	,	,	O
enveloped	enveloped	JJ	O
and	and	CC	O
positive	positive	JJ	O
senses	sense	NNS	O
that	that	WDT	O
can	can	MD	O
infect	infect	VB	O
both	both	DT	O
animals	animal	NNS	O
and	and	CC	O
humans	human	NNS	B
.	.	.	O

CoVs	CoVs	NNP	O
,	,	,	O
along	along	IN	O
with	with	IN	O
Artierivirdae	Artierivirdae	NNP	O
and	and	CC	O
Roniviridae	Roniviridae	NNP	O
,	,	,	O
belong	belong	VBP	O
to	to	IN	O
the	the	DT	O
Coronaviridae	Coronaviridae	NNP	O
family	family	NN	O
in	in	IN	O
the	the	DT	O
order	order	NN	O
Nidovirales	nidovirale	NNS	O
.	.	.	O

These	these	DT	O
CoVs	CoVs	NNP	O
can	can	MD	O
infect	infect	VB	O
various	various	JJ	O
hosts	host	NNS	O
,	,	,	O
including	include	VBG	O
avian	avian	NNP	O
,	,	,	O
swine	swine	NNS	O
and	and	CC	O
humans	human	NNS	O
.	.	.	O

Human	human	JJ	O
coronaviruses	coronaviruse	NNS	O
represent	represent	VBP	O
a	a	DT	O
major	major	JJ	O
group	group	NN	O
of	of	IN	O
CoVs	CoVs	NNP	O
associated	associate	VBN	O
with	with	IN	O
various	various	JJ	O
respiratory	respiratory	JJ	O
diseases	disease	NNS	O
from	from	IN	O
common	common	JJ	O
cold	cold	NN	O
to	to	IN	O
serious	serious	JJ	O
pneumonia	pneumonia	NN	O
and	and	CC	O
bronchiolitis	bronchiolitis	VB	B
.	.	.	O

Today	today	NN	O
,	,	,	O
HCoVs	HCoVs	NNP	O
are	be	VBP	O
recognised	recognise	VBN	O
as	as	IN	O
one	one	CD	O
of	of	IN	O
the	the	DT	O
fastest	fast	RBS	O
-	-	HYPH	O
evolving	evolve	VBG	O
viruses	virus	NNS	O
derived	derive	VBN	O
from	from	IN	O
their	-PRON-	PRP$	O
characteristic	characteristic	JJ	O
high	high	JJ	O
genomic	genomic	JJ	O
nucleotide	nucleotide	JJ	O
replacement	replacement	NN	O
rates	rate	NNS	O
and	and	CC	O
recombination	recombination	NN	B
.	.	.	O

Severe	Severe	NNP	O
Acute	Acute	NNP	O
Respiratory	Respiratory	NNP	O
Syndrome	Syndrome	NNP	O
,	,	,	O
the	the	DT	O
first	first	JJ	O
confirmed	confirm	VBN	O
atypical	atypical	JJ	O
pneumonia	pneumonia	NN	O
in	in	IN	O
China	China	NNP	O
's	's	POS	O
Guangdong	Guangdong	NNP	O
province	province	NN	O
,	,	,	O
has	have	VBZ	O
spread	spread	VBN	O
to	to	IN	O
several	several	JJ	O
countries	country	NNS	O
.	.	.	O

The	the	DT	O
most	most	RBS	O
common	common	JJ	O
symptoms	symptom	NNS	O
of	of	IN	O
SARS	SARS	NNP	O
include	include	VBP	O
coughing	cough	VBG	O
,	,	,	O
high	high	JJ	O
fever	fever	NN	O
>	>	NFP	O
38âÂ	38âÂ	NNP	O
°	°	,	O
C	C	NNP	O
,	,	,	O
chills	chills	NNP	O
,	,	,	O
convulsions	convulsion	NNS	O
,	,	,	O
headaches	headache	NNS	O
,	,	,	O
dizziness	dizziness	NN	O
and	and	CC	O
progressive	progressive	JJ	O
radiographic	radiographic	JJ	O
changes	change	NNS	O
of	of	IN	O
the	the	DT	O
chest	chest	NN	O
and	and	CC	O
lymphopenia	lymphopenia	JJ	B
.	.	.	O

The	the	DT	O
severity	severity	NN	O
of	of	IN	O
the	the	DT	O
disease	disease	NN	O
shows	show	VBZ	O
a	a	DT	O
death	death	NN	O
rate	rate	NN	O
of	of	IN	O
about	about	IN	O
3	3	CD	O
%	%	NN	O
to	to	IN	O
6	6	CD	O
%	%	NN	O
,	,	,	O
although	although	IN	O
this	this	DT	O
rate	rate	NN	O
could	could	MD	O
rise	rise	VB	O
up	up	IN	O
to	to	TO	O
43	43	CD	O
%	%	NN	O
to	to	IN	O
55	55	CD	O
%	%	NN	O
for	for	IN	O
senior	senior	JJ	O
citizens	citizen	NNS	O
older	old	JJR	O
than	than	IN	O
60	60	CD	O
years	year	NNS	B
.	.	.	O

The	the	DT	O
primary	primary	JJ	O
epidemic	epidemic	NN	O
of	of	IN	O
SARS	SARS	NNP	O
was	be	VBD	O
eventually	eventually	RB	O
controlled	control	VBN	O
,	,	,	O
but	but	CC	O
a	a	DT	O
SARS	SARS	NNP	O
CoV	CoV	NNP	O
-	-	HYPH	O
like	like	JJ	O
virus	virus	NN	O
was	be	VBD	O
detected	detect	VBN	O
in	in	IN	O
Chinese	chinese	JJ	O
bats	bat	NNS	B
,	,	,	B
.	.	.	O

Besides	besides	RB	O
,	,	,	O
a	a	DT	O
recent	recent	JJ	O
pandemic	pandemic	NN	O
of	of	IN	O
middle	middle	JJ	O
east	east	NNP	O
respiratory	respiratory	JJ	O
syndrome	syndrome	NN	O
caused	cause	VBN	O
by	by	IN	O
a	a	DT	O
novel	novel	JJ	O
coronavirus	coronavirus	NN	O
MERS	MERS	NNP	O
-	-	HYPH	O
CoV	CoV	NNP	O
raises	raise	VBZ	O
fear	fear	NN	O
of	of	IN	O
possible	possible	JJ	O
recurrence	recurrence	NN	O
of	of	IN	O
SARS	SARS	NNP	O
or	or	CC	O
related	relate	VBN	O
dangerous	dangerous	JJ	O
diseases	disease	NNS	B
,	,	,	B
.	.	.	O

Since	since	IN	O
there	there	EX	O
is	be	VBZ	O
no	no	DT	O
vaccine	vaccine	NN	O
and	and	CC	O
effective	effective	JJ	O
therapy	therapy	NN	O
for	for	IN	O
these	these	DT	O
viral	viral	JJ	O
infections	infection	NNS	O
,	,	,	O
developing	develop	VBG	O
anti	anti	JJ	O
-	-	JJ	O
SARS	sars	JJ	O
drugs	drug	NNS	O
against	against	IN	O
future	future	JJ	O
outbreaks	outbreak	NNS	O
remains	remain	VBZ	O
a	a	DT	O
formidable	formidable	JJ	O
challenge	challenge	NN	O
.	.	.	O

SARS-	SARS-	NNP	O
and	and	CC	O
MERS	MERS	NNP	O
-	-	HYPH	O
CoVs	CoVs	NNP	O
genomes	genome	NNS	O
contain	contain	VBP	O
two	two	CD	O
open	open	JJ	O
reading	reading	NN	O
frames	frame	VBZ	O
ORF1a	ORF1a	NNP	O
and	and	CC	O
ORF1b	ORF1b	NNP	O
translated	translate	VBD	O
to	to	IN	O
two	two	CD	O
respective	respective	JJ	O
viral	viral	JJ	O
polyproteins	polyprotein	NNS	O
pp1a	pp1a	NNP	O
and	and	CC	O
pp1ab	pp1ab	NNP	O
by	by	IN	O
host	host	NN	O
ribosomes	ribosome	NNS	O
.	.	.	O

ORF1a	orf1a	ADD	O
encodes	encode	VBZ	O
two	two	CD	O
cysteine	cysteine	NN	O
proteases	protease	NNS	O
,	,	,	O
a	a	DT	O
papain	papain	NN	O
-	-	HYPH	O
like	like	JJ	O
protease	protease	NN	O
and	and	CC	O
a	a	DT	O
3C	3c	NN	O
-	-	HYPH	O
like	like	JJ	O
protease	protease	NN	O
.	.	.	O

While	while	IN	O
PLpro	PLpro	NNP	O
cuts	cut	VBZ	O
the	the	DT	O
first	first	JJ	O
three	three	CD	O
cleavage	cleavage	NN	O
sites	site	NNS	O
of	of	IN	O
its	-PRON-	PRP$	O
polyprotein	polyprotein	NN	O
,	,	,	O
3CLpro	3clpro	CD	O
is	be	VBZ	O
responsible	responsible	JJ	O
for	for	IN	O
cleavage	cleavage	NN	O
of	of	IN	O
the	the	DT	O
remaining	remain	VBG	O
11	11	CD	O
locations	location	NNS	O
resulting	result	VBG	O
in	in	IN	O
release	release	NN	O
of	of	IN	O
a	a	DT	O
total	total	NN	O
of	of	IN	O
16	16	CD	O
non	non	JJ	O
-	-	JJ	O
structural	structural	JJ	O
proteins	protein	NNS	O
in	in	IN	O
both	both	DT	O
SARS-	SARS-	NNP	O
and	and	CC	O
MERS	MERS	NNP	O
-	-	HYPH	O
CoVs	CoVs	NNP	O
.	.	.	O

The	the	DT	O
homodimeric	homodimeric	JJ	O
form	form	NN	O
of	of	IN	O
3CLpro	3clpro	CD	O
is	be	VBZ	O
active	active	JJ	O
in	in	IN	O
the	the	DT	O
presence	presence	NN	O
of	of	IN	O
substrates	substrate	NNS	O
.	.	.	O

The	the	DT	O
crystal	crystal	NN	O
structures	structure	NNS	O
of	of	IN	O
both	both	DT	O
3CLpros	3CLpros	NNP	O
showed	show	VBD	O
that	that	IN	O
each	each	DT	O
monomer	monomer	NN	O
is	be	VBZ	O
composed	compose	VBN	O
of	of	IN	O
three	three	CD	O
structural	structural	JJ	O
domains	domain	NNS	O
:	:	:	O
domains	domain	NNS	O
I	-PRON-	PRP	O
and	and	CC	O
II	II	NNP	O
form	form	VBP	O
a	a	DT	O
chymotrypsin	chymotrypsin	NN	O
-	-	HYPH	O
like	like	JJ	O
architecture	architecture	NN	O
with	with	IN	O
a	a	DT	O
catalytic	catalytic	JJ	O
cysteine	cysteine	NN	O
and	and	CC	O
are	be	VBP	O
connected	connect	VBN	O
to	to	IN	O
a	a	DT	O
third	third	JJ	O
C	c	NN	O
-	-	HYPH	O
terminal	terminal	JJ	O
domain	domain	NN	O
via	via	IN	O
a	a	DT	O
long	long	JJ	O
loop	loop	NN	B
.	.	.	O

In	in	IN	O
the	the	DT	O
proteolytic	proteolytic	JJ	O
site	site	NN	O
,	,	,	O
all	all	DT	O
3CLpros	3clpro	NNS	O
prefer	prefer	VBP	O
glutamine	glutamine	NN	O
at	at	IN	O
P1	p1	NN	O
position	position	NN	O
and	and	CC	O
leucine	leucine	NN	O
,	,	,	O
basic	basic	JJ	O
residues	residue	NNS	O
,	,	,	O
small	small	JJ	O
hydrophobic	hydrophobic	JJ	O
residues	residue	NNS	O
at	at	IN	O
P2	P2	NNP	O
,	,	,	O
P3	P3	NNP	O
and	and	CC	O
P4	P4	NNP	O
positions	position	NNS	O
,	,	,	O
respectively	respectively	RB	B
.	.	.	O

At	at	IN	O
P1â²	P1â²	NNP	O
and	and	CC	O
P2â²	P2â²	NNP	O
positions	position	NNS	O
,	,	,	O
small	small	JJ	O
residues	residue	NNS	O
are	be	VBP	O
required	require	VBN	O
.	.	.	O

However	however	RB	O
,	,	,	O
P3â²	p3â²	JJ	O
position	position	NN	O
shows	show	VBZ	O
no	no	DT	O
strong	strong	JJ	O
preference	preference	NN	O
.	.	.	O

Since	since	IN	O
the	the	DT	O
autocleavage	autocleavage	NN	O
process	process	NN	O
is	be	VBZ	O
essential	essential	JJ	O
for	for	IN	O
viral	viral	JJ	O
propagation	propagation	NN	O
,	,	,	O
3CLpro	3clpro	CD	O
is	be	VBZ	O
a	a	DT	O
good	good	JJ	O
drug	drug	NN	O
target	target	NN	O
for	for	IN	O
anti	anti	JJ	O
-	-	JJ	O
coronaviral	coronaviral	JJ	O
infection	infection	NN	O
.	.	.	O

In	in	IN	O
this	this	DT	O
study	study	NN	O
,	,	,	O
we	-PRON-	PRP	O
employed	employ	VBD	O
a	a	DT	O
proteolytic	proteolytic	JJ	O
method	method	NN	O
to	to	TO	O
probe	probe	VB	O
SARS	SARS	NNP	O
-	-	HYPH	O
CoV	CoV	NNP	O
3CLpro	3clpro	CD	O
inhibitory	inhibitory	JJ	O
compounds	compound	NNS	O
.	.	.	O

A	a	DT	O
synthetic	synthetic	JJ	O
peptide	peptide	NN	O
labelled	label	VBN	O
with	with	IN	O
an	an	DT	O
Edans	Edans	NNP	O
-	-	HYPH	O
Dabcyl	dabcyl	NN	O
FRET	FRET	NNP	O
pair	pair	NN	B
was	be	VBD	O
used	use	VBN	O
to	to	TO	O
search	search	VB	O
SARS	SARS	NNP	O
-	-	HYPH	O
CoV	CoV	NNP	O
3CLpro	3clpro	CD	O
inhibitory	inhibitory	JJ	O
compounds	compound	VBZ	O
against	against	IN	O
a	a	DT	O
flavonoid	flavonoid	JJ	O
library	library	NN	O
.	.	.	O

Recent	recent	JJ	O
studies	study	NNS	O
showed	show	VBD	O
that	that	IN	O
flavonoids	flavonoid	NNS	O
have	have	VBP	O
antiviral	antiviral	JJ	O
activity	activity	NN	O
in	in	IN	O
some	some	DT	O
viruses	virus	NNS	O
including	include	VBG	O
SARS	SARS	NNP	O
-	-	HYPH	O
CoV	CoV	NNP	B
.	.	.	O

However	however	RB	O
,	,	,	O
a	a	DT	O
molecular	molecular	JJ	O
level	level	NN	O
study	study	NN	O
has	have	VBZ	O
not	not	RB	O
been	be	VBN	O
reported	report	VBN	O
for	for	IN	O
SARS	SARS	NNP	O
-	-	HYPH	O
CoV.	CoV.	NNP	O
Therefore	Therefore	NNP	O
,	,	,	O
we	-PRON-	PRP	O
performed	perform	VBD	O
the	the	DT	O
proteolytic	proteolytic	JJ	O
assay	assay	NN	O
with	with	IN	O
flavonoids	flavonoid	NNS	O
followed	follow	VBN	O
by	by	IN	O
an	an	DT	O
induced	induce	VBN	O
-	-	HYPH	O
fit	fit	NN	O
docking	docking	NN	O
experiment	experiment	NN	O
with	with	IN	O
top	top	JJ	O
hits	hit	NNS	O
.	.	.	O

With	with	IN	O
the	the	DT	O
results	result	NNS	O
,	,	,	O
we	-PRON-	PRP	O
tried	try	VBD	O
to	to	TO	O
deduce	deduce	VB	O
a	a	DT	O
structural	structural	JJ	O
and	and	CC	O
functional	functional	JJ	O
relationship	relationship	NN	O
of	of	IN	O
flavonoids	flavonoid	NNS	O
crucial	crucial	JJ	O
to	to	IN	O
binding	bind	VBG	O
with	with	IN	O
SARS	SARS	NNP	O
-	-	HYPH	O
CoV	CoV	NNP	O
3CLpro	3clpro	CD	O
.	.	.	O

The	the	DT	O
information	information	NN	O
can	can	MD	O
be	be	VB	O
applied	apply	VBN	O
to	to	TO	O
develop	develop	VB	O
synthetic	synthetic	JJ	O
compounds	compound	NNS	O
with	with	IN	O
better	well	JJR	O
affinities	affinity	NNS	O
.	.	.	O

The	the	DT	O
coding	code	VBG	O
sequence	sequence	NN	O
of	of	IN	O
SARS	SARS	NNP	O
-	-	HYPH	O
CoV	CoV	NNP	O
nsp5-pp1a	nsp5-pp1a	NNP	O
/	/	SYM	O
pp1ab	pp1ab	NNP	O
3CL	3CL	NNP	O
protease	protease	NN	O
was	be	VBD	O
obtained	obtain	VBN	O
at	at	IN	O
the	the	DT	O
NCBI	NCBI	NNP	O
database	database	NN	O
.	.	.	O

The	the	DT	O
catalytic	catalytic	JJ	O
domain	domain	NN	O
of	of	IN	O
3CLpro	3clpro	CD	O
M1â¼T196	M1â¼T196	NNP	O
was	be	VBD	O
synthesised	synthesise	VBN	O
chemically	chemically	RB	O
by	by	IN	O
Bioneer	Bioneer	NNP	O
and	and	CC	O
cloned	clone	VBN	O
into	into	IN	O
a	a	DT	O
bacteriophage	bacteriophage	NN	O
T7-based	t7-base	VBN	O
expression	expression	NN	O
vector	vector	NN	O
,	,	,	O
pBT7	pBT7	NNP	O
.	.	.	O

The	the	DT	O
plasmid	plasmid	NN	O
DNA	DNA	NNP	O
was	be	VBD	O
transformed	transform	VBN	O
into	into	IN	O
E.	E.	NNP	O
coli	coli	NNS	O
BL21	BL21	NNP	O
for	for	IN	O
protein	protein	NN	O
expression	expression	NN	O
.	.	.	O

E.	E.	NNP	O
coli	coli	NNS	O
BL21	BL21	NNP	O
cells	cell	NNS	O
were	be	VBD	O
grown	grow	VBN	O
on	on	IN	O
LuriaâBertani	LuriaâBertani	NNP	O
agar	agar	NN	O
plates	plate	NNS	O
containing	contain	VBG	O
150âÎ¼g	150âî¼g	CD	O
mlâ1	mlâ1	NN	O
ampicillin	ampicillin	NN	O
.	.	.	O

Several	several	JJ	O
colonies	colony	NNS	O
were	be	VBD	O
picked	pick	VBN	O
and	and	CC	O
grown	grow	VBN	O
in	in	IN	O
capped	capped	JJ	O
test	test	NN	O
tubes	tube	NNS	O
with	with	IN	O
10âml	10âml	CD	O
LB	LB	NNP	O
broth	broth	NN	O
containing	contain	VBG	O
150âÎ¼g	150âî¼g	CD	O
mlâ1	mlâ1	NNS	O
ampicillin	ampicillin	NN	O
.	.	.	O

A	a	DT	O
cell	cell	NN	O
stock	stock	NN	O
composed	compose	VBN	O
of	of	IN	O
0.85âml	0.85âml	NNP	O
culture	culture	NN	O
and	and	CC	O
0.15âml	0.15âml	NNP	O
glycerol	glycerol	NN	O
was	be	VBD	O
prepared	prepare	VBN	O
and	and	CC	O
frozen	freeze	VBN	O
at	at	IN	O
193âK	193âk	CD	O
for	for	IN	O
use	use	NN	O
in	in	IN	O
a	a	DT	O
large	large	JJ	O
culture	culture	NN	O
.	.	.	O

The	the	DT	O
frozen	frozen	JJ	O
cell	cell	NN	O
stock	stock	NN	O
was	be	VBD	O
grown	grow	VBN	O
in	in	IN	O
5âml	5âml	CD	O
LB	LB	NNP	O
medium	medium	NN	O
and	and	CC	O
diluted	dilute	VBN	O
into	into	IN	O
1000âml	1000âml	CD	O
fresh	fresh	JJ	O
LB	LB	NNP	O
medium	medium	NN	O
.	.	.	O

The	the	DT	O
culture	culture	NN	O
was	be	VBD	O
incubated	incubate	VBN	O
at	at	IN	O
310âK	310âk	CD	O
with	with	IN	O
shaking	shake	VBG	O
until	until	IN	O
an	an	DT	O
OD600	od600	NN	O
of	of	IN	O
0.6â0.8	0.6â0.8	CD	O
was	be	VBD	O
reached	reach	VBN	O
.	.	.	O

At	at	IN	O
this	this	DT	O
point	point	NN	O
,	,	,	O
the	the	DT	O
expression	expression	NN	O
of	of	IN	O
the	the	DT	O
SARS	SARS	NNP	O
-	-	HYPH	O
CoV	CoV	NNP	O
3CLpro	3clpro	CD	O
was	be	VBD	O
induced	induce	VBN	O
using	use	VBG	O
isopropyl	isopropyl	NN	O
-	-	.	O
Î²-d-1-thiogalactopyranoside	î²-d-1-thiogalactopyranoside	NN	O
at	at	IN	O
a	a	DT	O
final	final	JJ	O
concentration	concentration	NN	O
of	of	IN	O
1âmM.	1âmm.	CD	O
The	the	DT	O
culture	culture	NN	O
was	be	VBD	O
further	further	RB	O
grown	grow	VBN	O
at	at	IN	O
310âK	310âk	CD	O
for	for	IN	O
3âh	3âh	CD	O
in	in	IN	O
a	a	DT	O
shaking	shake	VBG	O
incubator	incubator	NN	O
.	.	.	O

Cells	cell	NNS	O
were	be	VBD	O
harvested	harvest	VBN	O
by	by	IN	O
centrifugation	centrifugation	NN	O
at	at	IN	O
7650	7650	CD	O
g	g	NNP	O
6500	6500	CD	O
rev	rev	NNP	O
minâ1	minâ1	NNP	O
for	for	IN	O
10âmin	10âmin	NN	O
in	in	IN	O
a	a	DT	O
high	high	JJ	O
-	-	HYPH	O
speed	speed	NN	O
refrigerated	refrigerate	VBN	O
centrifuge	centrifuge	NN	O
at	at	IN	O
277âK.	277âk.	CD	O
The	the	DT	O
cultured	cultured	JJ	O
cell	cell	NN	O
paste	paste	NN	O
was	be	VBD	O
resuspended	resuspend	VBN	O
in	in	IN	O
25âml	25âml	CD	O
of	of	IN	O
a	a	DT	O
buffer	buffer	NN	O
consisting	consist	VBG	O
of	of	IN	O
50âmM	50âmm	CD	O
TrisâHCl	TrisâHCl	NNP	O
pH	pH	NNP	O
8	8	CD	O
,	,	,	O
100âmM	100âmm	CD	O
NaCl	NaCl	NNP	O
,	,	,	O
10âmM	10âmm	CD	O
imidazole	imidazole	NN	O
,	,	,	O
1âmM	1âmm	CD	O
phenylmethylsulfonyl	phenylmethylsulfonyl	NN	O
fluoride	fluoride	NN	O
,	,	,	O
10âÎ¼g	10âî¼g	JJ	O
mlâ1	mlâ1	NNS	O
DNase	dnase	IN	O
I.	i.	NN	O
The	the	DT	O
cell	cell	NN	O
suspension	suspension	NN	O
was	be	VBD	O
disrupted	disrupt	VBN	O
using	use	VBG	O
an	an	DT	O
ultrasonic	ultrasonic	JJ	O
cell	cell	NN	O
disruptor	disruptor	NN	O
.	.	.	O

Cell	cell	NN	O
debris	debris	NN	O
was	be	VBD	O
pelleted	pellete	VBN	O
by	by	IN	O
centrifugation	centrifugation	NN	O
at	at	IN	O
24,900	24,900	CD	O
g	g	NNP	O
15,000	15,000	CD	O
rev	rev	NNP	O
minâ1	minâ1	NNP	O
for	for	IN	O
30âmin	30âmin	NN	O
in	in	IN	O
a	a	DT	O
high	high	JJ	O
-	-	HYPH	O
speed	speed	NN	O
refrigerated	refrigerate	VBD	O
ultra	ultra	JJ	O
-	-	JJ	O
centrifuge	centrifuge	JJ	O
at	at	IN	O
277âK.	277âk.	CD	O
The	the	DT	O
protein	protein	NN	O
was	be	VBD	O
purified	purify	VBN	O
by	by	IN	O
cation	cation	NN	O
chromatography	chromatography	NN	O
using	use	VBG	O
a	a	DT	O
5âml	5âml	CD	O
Hi	Hi	NNP	O
-	-	HYPH	O
Trap	Trap	NNP	O
SP	SP	NNP	O
column	column	NN	O
.	.	.	O

The	the	DT	O
column	column	NN	O
was	be	VBD	O
equilibrated	equilibrate	VBN	O
with	with	IN	O
a	a	DT	O
buffer	buffer	NN	O
consisting	consist	VBG	O
of	of	IN	O
50âmM	50âmm	CD	O
MES	MES	NNP	O
pH	pH	NNP	O
6.5	6.5	CD	O
and	and	CC	O
the	the	DT	O
pooled	pool	VBN	O
fractions	fraction	NNS	O
were	be	VBD	O
loaded	load	VBN	O
.	.	.	O

The	the	DT	O
column	column	NN	O
was	be	VBD	O
eluted	elute	VBN	O
using	use	VBG	O
a	a	DT	O
linear	linear	JJ	O
NaCl	NaCl	NNP	O
gradient	gradient	NN	O
to	to	TO	O
1âM	1âm	CD	O
NaCl	NaCl	NNP	O
and	and	CC	O
the	the	DT	O
protein	protein	NN	O
was	be	VBD	O
eluted	elute	VBN	O
at	at	IN	O
0.23âM	0.23âM	NNP	O
NaCl	NaCl	NNP	O
.	.	.	O

SDS	SDS	NNP	O
-	-	HYPH	O
PAGE	PAGE	NNP	O
showed	show	VBD	O
one	one	CD	O
band	band	NN	O
around	around	IN	O
22âkDa	22âkda	CD	O
21895.09âDa	21895.09âda	NN	O
,	,	,	O
corresponding	correspond	VBG	O
to	to	IN	O
the	the	DT	O
molecular	molecular	JJ	O
weight	weight	NN	O
of	of	IN	O
the	the	DT	O
catalytic	catalytic	JJ	O
domain	domain	NN	O
of	of	IN	O
SARS	SARS	NNP	O
-	-	HYPH	O
CoV	CoV	NNP	O
3CLpro	3clpro	CD	O
.	.	.	O

The	the	DT	O
protein	protein	NN	O
was	be	VBD	O
concentrated	concentrate	VBN	O
to	to	IN	O
16âmg	16âmg	CD	O
mlâ1	mlâ1	NN	O
for	for	IN	O
the	the	DT	O
protease	protease	JJ	O
assay	assay	NN	O
in	in	IN	O
a	a	DT	O
buffer	buffer	NN	O
consisting	consist	VBG	O
of	of	IN	O
0.23âM	0.23âM	.	O
NaCl	NaCl	NNP	O
and	and	CC	O
50âmM	50âmm	CD	O
MES	MES	NNP	O
pH	pH	NNP	O
6.5	6.5	CD	O
.	.	.	O

The	the	DT	O
custom	custom	RB	O
-	-	HYPH	O
synthesised	synthesise	VBN	O
fluorogenic	fluorogenic	NN	O
substrate	substrate	NN	O
,	,	,	O
DABCYL	DABCYL	NNP	O
-	-	HYPH	O
KTSAVLQSGFRKME	KTSAVLQSGFRKME	NNP	O
-	-	HYPH	O
EDANS	EDANS	NNP	O
,	,	,	O
was	be	VBD	O
used	use	VBN	O
as	as	IN	O
a	a	DT	O
substrate	substrate	NN	O
for	for	IN	O
the	the	DT	O
proteolytic	proteolytic	JJ	O
assay	assay	NN	O
using	use	VBG	O
the	the	DT	O
SARS	SARS	NNP	O
-	-	HYPH	O
CoV	CoV	NNP	O
3CLpro	3clpro	CD	B
.	.	.	O

This	this	DT	O
substrate	substrate	NN	O
contains	contain	VBZ	O
the	the	DT	O
nsp4	nsp4	NN	O
/	/	SYM	O
nsp5	nsp5	NN	O
cleavage	cleavage	NN	O
sequence	sequence	NN	O
,	,	,	O
GVLQâSG	GVLQâSG	NNP	B
,	,	,	O
and	and	CC	O
works	work	VBZ	O
as	as	IN	O
a	a	DT	O
generic	generic	JJ	O
peptide	peptide	NN	O
substrate	substrate	NN	O
for	for	IN	O
many	many	JJ	O
coronavirus	coronavirus	NN	O
including	include	VBG	O
the	the	DT	O
SARS	SARS	NNP	O
-	-	HYPH	O
CoV	CoV	NNP	O
3CLpro	3clpro	CD	O
.	.	.	O

The	the	DT	O
peptide	peptide	NN	O
was	be	VBD	O
dissolved	dissolve	VBN	O
in	in	IN	O
distilled	distilled	JJ	O
water	water	NN	O
and	and	CC	O
incubated	incubate	VBD	O
with	with	IN	O
each	each	DT	O
protease	protease	NN	O
.	.	.	O

A	a	DT	O
SpectraMax	SpectraMax	NNP	O
i3x	i3x	NNP	O
Multi	multi	JJ	O
-	-	JJ	O
mode	mode	JJ	O
microplate	microplate	NN	O
reader	reader	NN	O
was	be	VBD	O
used	use	VBN	O
to	to	TO	O
measure	measure	VB	O
spectral	spectral	NN	O
-	-	HYPH	O
based	base	VBN	O
fluorescence	fluorescence	NN	O
.	.	.	O

The	the	DT	O
proteolytic	proteolytic	JJ	O
activity	activity	NN	O
was	be	VBD	O
determined	determine	VBN	O
at	at	IN	O
310âK	310âk	CD	O
by	by	IN	O
following	follow	VBG	O
the	the	DT	O
increase	increase	NN	O
in	in	IN	O
fluorescence	fluorescence	NN	O
Î»excitation	î»excitation	NN	O
=	=	SYM	O
340ânm	340ânm	CD	O
,	,	,	O
Î»emission	î»emission	CD	O
=	=	SYM	O
490ânm	490ânm	CD	O
,	,	,	O
bandwidths	bandwidth	NNS	O
=	=	SYM	O
9	9	CD	O
,	,	,	O
15ânm	15ânm	CD	O
,	,	,	O
respectively	respectively	RB	O
of	of	IN	O
EDANS	EDANS	NNP	O
upon	upon	IN	O
peptide	peptide	JJ	O
hydrolysis	hydrolysis	NN	O
as	as	IN	O
a	a	DT	O
function	function	NN	O
of	of	IN	O
time	time	NN	O
.	.	.	O

Assays	assay	NNS	O
were	be	VBD	O
conducted	conduct	VBN	O
in	in	IN	O
black	black	JJ	O
,	,	,	O
96-well	96-well	CD	O
plates	plate	NNS	O
in	in	IN	O
300âÎ¼l	300âî¼l	CD	O
assay	assay	NNP	O
buffers	buffer	NNS	O
containing	contain	VBG	O
protease	protease	NN	O
and	and	CC	O
substrate	substrate	VB	O
as	as	IN	O
follow	follow	NN	O
;	;	:	O
For	for	IN	O
the	the	DT	O
SARS	SARS	NNP	O
-	-	HYPH	O
CoV	CoV	NNP	O
3CLpro	3clpro	CD	O
assay	assay	NNP	O
,	,	,	O
4.05âÎ¼l	4.05âî¼l	CD	O
of	of	IN	O
0.074âmM	0.074âmm	NN	O
protease	protease	NN	O
containing	contain	VBG	O
50âmM	50âmm	CD	O
Tris	Tris	NNP	O
pH	pH	NNP	O
6.5	6.5	CD	O
was	be	VBD	O
incubated	incubate	VBN	O
with	with	IN	O
7.5âÎ¼l	7.5âî¼l	NN	O
of	of	IN	O
0.1âmM	0.1âmm	CD	O
substrate	substrate	NN	O
at	at	IN	O
310âK	310âk	CD	O
for	for	IN	O
2âh	2âh	CD	O
before	before	IN	O
measuring	measure	VBG	O
Relative	Relative	NNP	O
Fluorescence	Fluorescence	NNP	O
Unit	Unit	NNP	O
.	.	.	O

Before	before	IN	O
the	the	DT	O
assay	assay	NN	O
,	,	,	O
the	the	DT	O
emission	emission	NN	O
spectra	spectra	NN	O
of	of	IN	O
64	64	CD	O
flavonoids	flavonoid	NNS	O
were	be	VBD	O
surveyed	survey	VBN	O
after	after	IN	O
illuminating	illuminate	VBG	O
at	at	IN	O
340ânm	340ânm	CD	O
to	to	TO	O
avoid	avoid	VB	O
the	the	DT	O
overlapping	overlapping	NN	O
with	with	IN	O
the	the	DT	O
emission	emission	NN	O
spectrum	spectrum	NN	O
of	of	IN	O
EDANS	EDANS	NNP	O
.	.	.	O

Every	every	DT	O
compound	compound	NN	O
was	be	VBD	O
suitable	suitable	JJ	O
to	to	TO	O
be	be	VB	O
tested	test	VBN	O
.	.	.	O

The	the	DT	O
final	final	JJ	O
concentration	concentration	NN	O
of	of	IN	O
the	the	DT	O
protease	protease	NN	O
,	,	,	O
peptide	peptide	NN	O
and	and	CC	O
chemical	chemical	NN	O
used	use	VBN	O
at	at	IN	O
the	the	DT	O
assay	assay	NN	O
was	be	VBD	O
1	1	CD	O
,	,	,	O
2.5	2.5	CD	O
and	and	CC	O
20âÎ¼M	20âî¼m	CD	O
each	each	DT	O
.	.	.	O

At	at	IN	O
first	first	RB	O
,	,	,	O
the	the	DT	O
SARS	SARS	NNP	O
-	-	HYPH	O
CoV	CoV	NNP	O
3CLpro	3clpro	CD	O
and	and	CC	O
chemical	chemical	NN	O
were	be	VBD	O
mixed	mixed	JJ	O
and	and	CC	O
pre	pre	VBN	O
-	-	VBN	O
incubated	incubate	VBN	O
at	at	IN	O
room	room	NN	O
temperature	temperature	NN	O
for	for	IN	O
1âh	1âh	CD	O
.	.	.	O

The	the	DT	O
reaction	reaction	NN	O
was	be	VBD	O
initiated	initiate	VBN	O
by	by	IN	O
the	the	DT	O
addition	addition	NN	O
of	of	IN	O
the	the	DT	O
substrate	substrate	NN	O
and	and	CC	O
each	each	DT	O
well	well	RB	O
was	be	VBD	O
incubated	incubate	VBN	O
at	at	IN	O
310âK	310âk	CD	O
for	for	IN	O
16âh	16âh	CD	O
.	.	.	O

After	after	IN	O
that	that	DT	O
,	,	,	O
we	-PRON-	PRP	O
measured	measure	VBD	O
the	the	DT	O
fluorescence	fluorescence	NN	O
of	of	IN	O
the	the	DT	O
mixture	mixture	NN	O
on	on	IN	O
the	the	DT	O
black	black	JJ	O
96-well	96-well	CD	O
plate	plate	NN	O
using	use	VBG	O
the	the	DT	O
endpoint	endpoint	NN	O
mode	mode	NN	O
of	of	IN	O
SpectraMax	SpectraMax	NNP	O
i3x	i3x	NNP	O
where	where	WRB	O
the	the	DT	O
excitation	excitation	NN	O
wavelength	wavelength	NN	O
was	be	VBD	O
fixed	fix	VBN	O
to	to	IN	O
340ânm	340ânm	CD	O
and	and	CC	O
the	the	DT	O
emission	emission	NN	O
wavelength	wavelength	NN	O
was	be	VBD	O
set	set	VBN	O
to	to	IN	O
490ânm	490ânm	CD	O
using	use	VBG	O
9	9	CD	O
,	,	,	O
15ânm	15ânm	CD	O
bandwidth	bandwidth	NN	O
,	,	,	O
respectively	respectively	RB	O
.	.	.	O

All	all	DT	O
reactions	reaction	NNS	O
were	be	VBD	O
carried	carry	VBN	O
out	out	RP	O
in	in	IN	O
triplicate	triplicate	NN	O
.	.	.	O

Among	among	IN	O
the	the	DT	O
first	first	JJ	O
64	64	CD	O
flavonoids	flavonoid	NNS	O
,	,	,	O
three	three	CD	O
of	of	IN	O
them	-PRON-	PRP	O
were	be	VBD	O
picked	pick	VBN	O
up	up	RP	O
to	to	IN	O
further	further	JJ	O
assay	assay	NN	O
at	at	IN	O
a	a	DT	O
concentration	concentration	NN	O
range	range	NN	O
of	of	IN	O
2â320âÎ¼M.	2â320âî¼m.	CD	O
The	the	DT	O
IC50	IC50	NNP	O
value	value	NN	O
which	which	WDT	O
is	be	VBZ	O
the	the	DT	O
value	value	NN	O
causing	cause	VBG	O
50	50	CD	O
%	%	NN	O
inhibition	inhibition	NN	O
of	of	IN	O
the	the	DT	O
catalytic	catalytic	JJ	O
activity	activity	NN	O
of	of	IN	O
the	the	DT	O
SARS	SARS	NNP	O
-	-	HYPH	O
CoV	CoV	NNP	O
3CLpro	3clpro	CD	O
was	be	VBD	O
calculated	calculate	VBN	O
by	by	IN	O
nonlinear	nonlinear	JJ	O
regression	regression	NN	O
analysis	analysis	NN	O
using	use	VBG	O
GraphPad	GraphPad	NNP	O
Prism	Prism	NNP	O
7.03	7.03	CD	O
.	.	.	O

The	the	DT	O
proteolytic	proteolytic	JJ	O
assay	assay	NN	O
using	use	VBG	O
the	the	DT	O
SARS	SARS	NNP	O
-	-	HYPH	O
CoV	CoV	NNP	O
3CLpro	3clpro	CD	O
in	in	IN	O
the	the	DT	O
presence	presence	NN	O
of	of	IN	O
Triton	Triton	NNP	O
X-100	X-100	NNP	O
has	have	VBZ	O
been	be	VBN	O
performed	perform	VBN	O
to	to	TO	O
differentiate	differentiate	VB	O
the	the	DT	O
artificial	artificial	JJ	O
inhibitory	inhibitory	JJ	O
activity	activity	NN	O
of	of	IN	O
chemicals	chemical	NNS	O
through	through	IN	O
non	non	JJ	O
-	-	JJ	O
specific	specific	JJ	O
binding	bind	VBG	O
with	with	IN	O
proteases	protease	NNS	O
by	by	IN	O
forming	form	VBG	O
aggregate	aggregate	NN	O
or	or	CC	O
complexation	complexation	NN	O
.	.	.	O

The	the	DT	O
concentration	concentration	NN	O
used	use	VBN	O
in	in	IN	O
this	this	DT	O
study	study	NN	O
was	be	VBD	O
0.01	0.01	CD	O
%	%	NN	O
.	.	.	O

To	to	TO	O
confirm	confirm	VB	O
the	the	DT	O
feasibility	feasibility	NN	O
of	of	IN	O
the	the	DT	O
assay	assay	NN	O
method	method	NN	O
independently	independently	RB	O
,	,	,	O
the	the	DT	O
fluorescence	fluorescence	NN	O
spectra	spectra	NNP	O
from	from	IN	O
the	the	DT	O
tryptophan	tryptophan	NNP	O
of	of	IN	O
the	the	DT	O
SARS	SARS	NNP	O
-	-	HYPH	O
CoV	CoV	NNP	O
3CLpro	3clpro	CD	O
with	with	IN	O
candidate	candidate	NN	O
inhibitors	inhibitor	NNS	O
were	be	VBD	O
investigated	investigate	VBN	B
.	.	.	O

The	the	DT	O
fluorescence	fluorescence	NN	O
measurements	measurement	NNS	O
were	be	VBD	O
recorded	record	VBN	O
with	with	IN	O
a	a	DT	O
SpectraMax	SpectraMax	NNP	O
i3x	i3x	ADD	O
Multi	multi	JJ	O
-	-	JJ	O
mode	mode	JJ	O
microplate	microplate	NN	O
reader	reader	NN	O
at	at	IN	O
excitation	excitation	NN	O
and	and	CC	O
emission	emission	NN	O
wavelengths	wavelength	NNS	O
of	of	IN	O
290ânm	290ânm	CD	O
and	and	CC	O
300â500ânm	300â500ânm	CD	O
,	,	,	O
respectively	respectively	RB	O
.	.	.	O

The	the	DT	O
optimal	optimal	JJ	O
excitation	excitation	NN	O
and	and	CC	O
emission	emission	NN	O
wavelengths	wavelength	NNS	O
were	be	VBD	O
determined	determine	VBN	O
by	by	IN	O
SoftMax	SoftMax	NNP	O
Pro	Pro	NNP	O
.	.	.	O

One	one	CD	O
tryptophan	tryptophan	NN	O
of	of	IN	O
the	the	DT	O
SARS	SARS	NNP	O
-	-	HYPH	O
CoV	CoV	NNP	O
3CLpro	3clpro	CD	O
showed	show	VBD	O
a	a	DT	O
fluorescence	fluorescence	NN	O
emission	emission	NN	O
with	with	IN	O
a	a	DT	O
peak	peak	NN	O
at	at	IN	O
350ânm	350ânm	CD	O
after	after	IN	O
the	the	DT	O
excitation	excitation	NN	O
at	at	IN	O
the	the	DT	O
wavelength	wavelength	NN	O
of	of	IN	O
290ânm	290ânm	CD	O
.	.	.	O

In	in	IN	O
contrast	contrast	NN	O
,	,	,	O
the	the	DT	O
flavonoids	flavonoid	NNS	O
were	be	VBD	O
almost	almost	RB	O
non	non	JJ	O
-	-	JJ	O
fluorescent	fluorescent	JJ	O
under	under	IN	O
the	the	DT	O
same	same	JJ	O
experiment	experiment	NN	O
condition	condition	NN	O
.	.	.	O

Each	each	DT	O
40âÎ¼M	40âî¼m	CD	O
chemical	chemical	NN	O
was	be	VBD	O
incubated	incubate	VBN	O
with	with	IN	O
1âÎ¼M	1âî¼m	CD	O
the	the	DT	O
SARS	SARS	NNP	O
-	-	HYPH	O
CoV	CoV	NNP	O
3CLpro	3clpro	CD	O
for	for	IN	O
1âh	1âh	CD	O
and	and	CC	O
the	the	DT	O
fluorescence	fluorescence	NN	O
intensity	intensity	NN	O
of	of	IN	O
the	the	DT	O
mixture	mixture	NN	O
was	be	VBD	O
measured	measure	VBN	O
.	.	.	O

All	all	PDT	O
the	the	DT	O
docking	docking	NN	O
and	and	CC	O
scoring	score	VBG	O
calculation	calculation	NN	O
were	be	VBD	O
performed	perform	VBN	O
using	use	VBG	O
the	the	DT	O
SchrÃ¶dinger	SchrÃ¶dinger	NNP	O
software	software	NN	O
suite	suite	NN	O
.	.	.	O

The	the	DT	O
compounds	compound	NNS	O
were	be	VBD	O
extracted	extract	VBN	O
from	from	IN	O
the	the	DT	O
PubChem	PubChem	NNP	O
database	database	NN	O
in	in	IN	O
the	the	DT	O
SDF	SDF	NNP	O
format	format	NN	O
and	and	CC	O
were	be	VBD	O
combined	combine	VBN	O
in	in	IN	O
one	one	CD	O
file	file	NN	O
.	.	.	O

The	the	DT	O
file	file	NN	O
was	be	VBD	O
then	then	RB	O
imported	import	VBN	O
into	into	IN	O
Maestro	Maestro	NNP	O
and	and	CC	O
prepared	prepare	VBD	O
for	for	IN	O
docking	docking	NN	O
using	use	VBG	O
LigPrep	LigPrep	NNP	O
.	.	.	O

The	the	DT	O
atomic	atomic	JJ	O
coordinates	coordinate	NNS	O
of	of	IN	O
the	the	DT	O
crystal	crystal	NN	O
structure	structure	NN	O
of	of	IN	O
SARS	SARS	NNP	O
-	-	HYPH	O
CoV	CoV	NNP	O
3CLpro	3clpro	CD	O
were	be	VBD	O
retrieved	retrieve	VBN	O
from	from	IN	O
the	the	DT	O
Protein	Protein	NNP	O
Data	Data	NNPS	O
Bank	Bank	NNP	O
and	and	CC	O
prepared	prepare	VBN	O
by	by	IN	O
removing	remove	VBG	O
all	all	DT	O
solvent	solvent	NN	O
and	and	CC	O
adding	add	VBG	O
hydrogens	hydrogen	NNS	O
and	and	CC	O
minimal	minimal	JJ	O
minimisation	minimisation	NN	O
in	in	IN	O
the	the	DT	O
presence	presence	NN	O
of	of	IN	O
bound	bind	VBN	O
ligand	ligand	NNP	O
using	use	VBG	O
Protein	Protein	NNP	O
Preparation	Preparation	NNP	O
Wizard	Wizard	NNP	O
.	.	.	O

Ioniser	Ioniser	NNP	O
was	be	VBD	O
used	use	VBN	O
to	to	TO	O
generate	generate	VB	O
an	an	DT	O
ionised	ionised	JJ	O
state	state	NN	O
of	of	IN	O
all	all	DT	O
compounds	compound	NNS	O
at	at	IN	O
the	the	DT	O
target	target	NN	O
pH	pH	NNP	O
7âÂ±â2	7ââ±â2	CD	O
.	.	.	O

This	this	DT	O
prepared	prepared	JJ	O
low	low	JJ	O
-	-	HYPH	O
energy	energy	NN	O
conformers	conformer	NNS	O
of	of	IN	O
the	the	DT	O
ligand	ligand	NN	O
were	be	VBD	O
taken	take	VBN	O
as	as	IN	O
the	the	DT	O
input	input	NN	O
for	for	IN	O
an	an	DT	O
induced	induce	VBN	O
-	-	HYPH	O
fit	fit	JJ	O
docking	docking	NN	O
.	.	.	O

The	the	DT	O
induced	induce	VBN	O
-	-	HYPH	O
fit	fit	NN	O
docking	docking	NN	O
protocol	protocol	JJ	B
was	be	VBD	O
run	run	VBN	O
from	from	IN	O
the	the	DT	O
graphical	graphical	JJ	O
user	user	NN	O
interface	interface	NN	O
accessible	accessible	JJ	O
within	within	IN	O
Maestro	Maestro	NNP	O
11.8.012	11.8.012	CD	O
.	.	.	O

Receptor	receptor	NN	O
sampling	sampling	NN	O
and	and	CC	O
refinement	refinement	NN	O
were	be	VBD	O
performed	perform	VBN	O
on	on	IN	O
residues	residue	NNS	O
within	within	IN	O
5âÃ	5âã	CD	O
of	of	IN	O
each	each	DT	O
ligand	ligand	NN	O
for	for	IN	O
each	each	DT	O
of	of	IN	O
the	the	DT	O
ligandâprotein	ligandâprotein	JJ	O
complexes	complex	NNS	O
.	.	.	O

With	with	IN	O
Prime	Prime	NNP	B
,	,	,	O
a	a	DT	O
sideâchain	sideâchain	NNP	O
sampling	sampling	NN	O
and	and	CC	O
prediction	prediction	NN	O
module	module	NN	O
,	,	,	O
as	as	RB	O
well	well	RB	O
as	as	IN	O
the	the	DT	O
backbone	backbone	NN	O
of	of	IN	O
the	the	DT	O
target	target	NN	O
protein	protein	NN	O
,	,	,	O
were	be	VBD	O
energy	energy	NN	O
minimised	minimise	VBN	O
.	.	.	O

A	a	DT	O
total	total	NN	O
of	of	IN	O
inducedâfit	inducedâfit	JJ	O
receptor	receptor	NN	O
conformations	conformation	NNS	O
were	be	VBD	O
generated	generate	VBN	O
for	for	IN	O
each	each	DT	O
of	of	IN	O
the	the	DT	O
ligands	ligand	NNS	O
.	.	.	O

Reâdocking	Reâdocking	NNP	O
was	be	VBD	O
performed	perform	VBN	O
with	with	IN	O
the	the	DT	O
test	test	NN	O
ligands	ligand	VBZ	O
into	into	IN	O
their	-PRON-	PRP$	O
respective	respective	JJ	O
structures	structure	NNS	O
that	that	WDT	O
are	be	VBP	O
within	within	IN	O
30âkcal	30âkcal	JJ	O
/	/	SYM	O
mol	mol	NN	O
of	of	IN	O
their	-PRON-	PRP$	O
lowest	low	JJS	O
energy	energy	NN	O
structure	structure	NN	O
.	.	.	O

Finally	finally	RB	O
,	,	,	O
the	the	DT	O
ligand	ligand	NN	O
poses	pose	NNS	O
were	be	VBD	O
scored	score	VBN	O
using	use	VBG	O
a	a	DT	O
combination	combination	NN	O
of	of	IN	O
Prime	Prime	NNP	O
and	and	CC	O
GlideScore	GlideScore	NNP	O
scoring	score	VBG	O
functions	function	NNS	B
.	.	.	O

The	the	DT	O
yield	yield	NN	O
of	of	IN	O
cell	cell	NN	O
harvested	harvest	VBN	O
for	for	IN	O
purification	purification	NN	O
of	of	IN	O
the	the	DT	O
catalytic	catalytic	JJ	O
domain	domain	NN	O
of	of	IN	O
SARS	SARS	NNP	O
-	-	HYPH	O
CoV	CoV	NNP	O
3CLpro	3clpro	CD	O
was	be	VBD	O
2.69âg	2.69âg	CD	O
per	per	IN	O
1000âml	1000âml	CD	O
of	of	IN	O
E.	E.	NNP	O
coli	coli	NNS	O
culture	culture	NN	O
.	.	.	O

The	the	DT	O
amount	amount	NN	O
of	of	IN	O
purified	purify	VBN	O
protein	protein	NN	O
synthesised	synthesise	VBN	O
with	with	IN	O
no	no	DT	O
-	-	HYPH	O
tag	tag	NN	O
was	be	VBD	O
16âmg	16âmg	CD	O
.	.	.	O

For	for	IN	O
storage	storage	NN	O
and	and	CC	O
assay	assay	NN	O
,	,	,	O
the	the	DT	O
protein	protein	NN	O
solution	solution	NN	O
was	be	VBD	O
concentrated	concentrate	VBN	O
to	to	IN	O
16âmg	16âmg	CD	O
mlâ1	mlâ1	NN	O
.	.	.	O

The	the	DT	O
concentrated	concentrated	JJ	O
solution	solution	NN	O
was	be	VBD	O
diluted	dilute	VBN	O
to	to	IN	O
1âÎ¼M	1âî¼m	CD	O
when	when	WRB	O
the	the	DT	O
inhibitory	inhibitory	NN	O
assay	assay	NNP	O
was	be	VBD	O
going	go	VBG	O
on	on	RP	O
.	.	.	O

A	a	DT	O
flavonoid	flavonoid	JJ	O
library	library	NN	O
consisting	consist	VBG	O
of	of	IN	O
10	10	CD	O
different	different	JJ	O
scaffolds	scaffold	NNS	O
was	be	VBD	O
also	also	RB	O
built	build	VBN	O
.	.	.	O

It	-PRON-	PRP	O
contains	contain	VBZ	O
five	five	CD	O
isoflavones	isoflavone	NNS	O
,	,	,	O
one	one	CD	O
isoflavane	isoflavane	NN	O
,	,	,	O
17	17	CD	O
flavones	flavone	NNS	O
,	,	,	O
11	11	CD	O
flavonols	flavonol	NNS	O
,	,	,	O
seven	seven	CD	O
flavanols	flavanol	NNS	O
,	,	,	O
seven	seven	CD	O
flavanones	flavanone	NNS	O
,	,	,	O
four	four	CD	O
flavanonol	flavanonol	NNS	O
,	,	,	O
one	one	CD	O
prenylflavonoid	prenylflavonoid	NN	O
,	,	,	O
nine	nine	CD	O
chalcones	chalcone	NNS	O
and	and	CC	O
two	two	CD	O
unclassified	unclassified	JJ	O
flavonoids	flavonoid	NNS	O
.	.	.	O

We	-PRON-	PRP	O
applied	apply	VBD	O
the	the	DT	O
library	library	NN	O
to	to	TO	O
assay	assay	VB	O
SARS	SARS	NNP	O
-	-	HYPH	O
CoV	CoV	NNP	O
3CLpro	3clpro	CD	O
.	.	.	O

Using	use	VBG	O
64	64	CD	O
flavonoids	flavonoid	NNS	O
,	,	,	O
an	an	DT	O
inhibitory	inhibitory	JJ	O
effect	effect	NN	O
of	of	IN	O
each	each	DT	O
compound	compound	NN	O
at	at	IN	O
20âÎ¼M	20âî¼m	CD	O
was	be	VBD	O
tested	test	VBN	O
.	.	.	O

Among	among	IN	O
them	-PRON-	PRP	O
,	,	,	O
herbacetin	herbacetin	NNP	O
3,4â²,5,7,8-pentahydroxyflavone	3,4â²,5,7,8-pentahydroxyflavone	CD	O
,	,	,	O
rhoifolin	rhoifolin	NN	O
and	and	CC	O
pectolinarin	pectolinarin	NNP	O
5,7-dihydroxy	5,7-dihydroxy	CD	O
4â²,6-dimethoxyflavone	4â²,6-dimethoxyflavone	CD	O
7-rutinoside	7-rutinoside	CD	O
were	be	VBD	O
found	find	VBN	O
to	to	TO	O
have	have	VB	O
prominent	prominent	JJ	O
inhibitory	inhibitory	JJ	O
activity	activity	NN	O
.	.	.	O

The	the	DT	O
binding	bind	VBG	O
affinity	affinity	NN	O
data	datum	NNS	O
were	be	VBD	O
plotted	plot	VBN	O
as	as	IN	O
log	log	NN	O
inhibitor	inhibitor	NN	O
concentration	concentration	NN	O
versus	versus	IN	O
percent	percent	NN	O
fluorescence	fluorescence	NN	O
inhibition	inhibition	NN	O
.	.	.	O

The	the	DT	O
three	three	CD	O
compounds	compound	NNS	O
showed	show	VBD	O
the	the	DT	O
severely	severely	RB	O
reduced	reduce	VBN	O
fluorescent	fluorescent	JJ	O
intensity	intensity	NN	O
and	and	CC	O
thus	thus	RB	O
represented	represent	VBD	O
their	-PRON-	PRP$	O
SARS	SARS	NNP	O
-	-	HYPH	O
CoV	CoV	NNP	O
3CLpro	3clpro	CD	O
inhibitory	inhibitory	JJ	O
activity	activity	NN	O
.	.	.	O

The	the	DT	O
IC50	IC50	NNP	O
values	value	NNS	O
were	be	VBD	O
calculated	calculate	VBN	O
from	from	IN	O
the	the	DT	O
dose	dose	RB	O
-	-	HYPH	O
dependent	dependent	JJ	O
inhibitory	inhibitory	JJ	O
curves	curve	NNS	O
of	of	IN	O
herbacetin	herbacetin	NNP	O
,	,	,	O
rhoifolin	rhoifolin	NNP	O
and	and	CC	O
pectolinarin	pectolinarin	NN	O
.	.	.	O

The	the	DT	O
measured	measured	JJ	O
values	value	NNS	O
were	be	VBD	O
33.17	33.17	CD	O
,	,	,	O
27.45	27.45	CD	O
and	and	CC	O
37.78âÎ¼M	37.78âî¼m	CD	O
,	,	,	O
respectively	respectively	RB	O
.	.	.	O

Since	since	IN	O
flavonoids	flavonoid	NNS	O
are	be	VBP	O
known	know	VBN	O
to	to	TO	O
be	be	VB	O
aggregated	aggregate	VBN	O
through	through	IN	O
complexity	complexity	NN	O
and	and	CC	O
thus	thus	RB	O
non	non	JJ	O
-	-	:	O
specifically	specifically	RB	O
inhibit	inhibit	VB	O
various	various	JJ	O
proteases	protease	NNS	O
,	,	,	O
the	the	DT	O
assay	assay	NN	O
in	in	IN	O
the	the	DT	O
presence	presence	NN	O
of	of	IN	O
Triton	Triton	NNP	O
X-100	X-100	NNP	O
was	be	VBD	O
also	also	RB	O
performed	perform	VBN	B
.	.	.	O

Before	before	IN	O
the	the	DT	O
examination	examination	NN	O
,	,	,	O
we	-PRON-	PRP	O
tested	test	VBD	O
the	the	DT	O
effects	effect	NNS	O
of	of	IN	O
Triton	Triton	NNP	O
X-100	X-100	NNP	O
on	on	IN	O
the	the	DT	O
catalytic	catalytic	JJ	O
activity	activity	NN	O
of	of	IN	O
the	the	DT	O
SARS	SARS	NNP	O
-	-	HYPH	O
CoV	CoV	NNP	O
3CLpro	3clpro	CD	O
.	.	.	O

As	as	IN	O
shown	show	VBN	O
in	in	IN	O
Supplementary	Supplementary	NNP	O
Figure	Figure	NNP	O
1	1	CD	O
,	,	,	O
only	only	RB	O
a	a	DT	O
slight	slight	JJ	O
increase	increase	NN	O
in	in	IN	O
catalyst	catalyst	NN	O
activity	activity	NN	O
was	be	VBD	O
observed	observe	VBN	O
up	up	IN	O
to	to	TO	O
0.1	0.1	CD	O
%	%	NN	O
Triton	Triton	NNP	O
X-100	X-100	NNP	O
.	.	.	O

Therefore	therefore	RB	O
,	,	,	O
the	the	DT	O
assay	assay	NN	O
was	be	VBD	O
performed	perform	VBN	O
at	at	IN	O
a	a	DT	O
concentration	concentration	NN	O
of	of	IN	O
0.01	0.01	CD	O
%	%	NN	O
Triton	Triton	NNP	O
X-100	X-100	VBZ	O
with	with	IN	O
no	no	DT	O
significant	significant	JJ	O
interference	interference	NN	O
detected	detect	VBN	O
.	.	.	O

The	the	DT	O
basic	basic	JJ	O
skeleton	skeleton	NN	O
structures	structure	NNS	O
of	of	IN	O
flavonoids	flavonoid	NNS	O
and	and	CC	O
their	-PRON-	PRP$	O
scaffolds	scaffold	NNS	O
.	.	.	O

Basic	basic	JJ	O
representative	representative	JJ	O
structures	structure	NNS	O
of	of	IN	O
the	the	DT	O
most	most	RBS	O
common	common	JJ	O
flavonoids	flavonoid	NNS	O
classified	classify	VBN	O
in	in	IN	O
this	this	DT	O
study	study	NN	O
were	be	VBD	O
drawn	draw	VBN	O
with	with	IN	O
rings	ring	NNS	O
and	and	CC	O
numbered	number	VBN	O
positions	position	NNS	O
.	.	.	O

Results	result	NNS	O
from	from	IN	O
the	the	DT	O
FRET	FRET	NNP	O
method	method	NN	O
.	.	.	O

Each	each	DT	O
data	data	NN	O
point	point	NN	O
represents	represent	VBZ	O
the	the	DT	O
effect	effect	NN	O
of	of	IN	O
each	each	DT	O
inhibitory	inhibitory	JJ	O
compound	compound	NN	O
against	against	IN	O
SARS	SARS	NNP	O
-	-	HYPH	O
CoV	CoV	NNP	O
3CLpro	3clpro	CD	O
compared	compare	VBN	O
to	to	IN	O
the	the	DT	O
control	control	NN	O
.	.	.	O

The	the	DT	O
RFU	RFU	NNP	O
are	be	VBP	O
plotted	plot	VBN	O
against	against	IN	O
the	the	DT	O
log	log	NN	O
-	-	HYPH	O
concentration	concentration	NN	O
of	of	IN	O
inhibitory	inhibitory	JJ	O
compounds	compound	NNS	O
.	.	.	O

Each	each	DT	O
dot	dot	NN	O
is	be	VBZ	O
expressed	express	VBN	O
as	as	IN	O
the	the	DT	O
meanâÂ±âstandard	meanâÂ±âstandard	NNP	O
error	error	NN	O
of	of	IN	O
the	the	DT	O
mean	mean	NN	O
nâ=â3	nâ=â3	NNP	O
.	.	.	O

RFU	RFU	NNP	O
:	:	:	O
Relative	Relative	NNP	O
Fluorescence	Fluorescence	NNP	O
Units	Units	NNPS	O
.	.	.	O

To	to	TO	O
independently	independently	RB	O
confirm	confirm	VB	O
the	the	DT	O
inhibitory	inhibitory	JJ	O
activity	activity	NN	O
of	of	IN	O
flavonoids	flavonoid	NNS	O
,	,	,	O
a	a	DT	O
general	general	JJ	O
tryptophan	tryptophan	NNP	O
-	-	HYPH	O
based	base	VBN	O
assay	assay	NNP	O
method	method	NN	O
was	be	VBD	O
employed	employ	VBN	O
.	.	.	O

Tryptophan	Tryptophan	NNP	O
was	be	VBD	O
well	well	RB	O
known	known	JJ	O
to	to	TO	O
emit	emit	VB	O
its	-PRON-	PRP$	O
fluorescence	fluorescence	NN	O
.	.	.	O

Therefore	therefore	RB	O
,	,	,	O
if	if	IN	O
tryptophan	tryptophan	NNP	O
is	be	VBZ	O
positioned	position	VBN	O
adequately	adequately	RB	O
in	in	IN	O
proteins	protein	NNS	O
,	,	,	O
the	the	DT	O
change	change	NN	O
of	of	IN	O
fluorescence	fluorescence	NN	O
intensity	intensity	NN	O
can	can	MD	O
reflect	reflect	VB	O
the	the	DT	O
binding	bind	VBG	O
state	state	NN	O
of	of	IN	O
chemicals	chemical	NNS	O
and	and	CC	O
be	be	VB	O
used	use	VBN	O
to	to	TO	O
judge	judge	VB	O
interaction	interaction	NN	O
between	between	IN	O
proteins	protein	NNS	O
and	and	CC	O
chemicals	chemical	NNS	O
.	.	.	O

The	the	DT	O
SARS	SARS	NNP	O
-	-	HYPH	O
CoV	CoV	NNP	O
3CLpro	3clpro	CD	O
contains	contain	VBZ	O
one	one	CD	O
tryptophan	tryptophan	NNP	O
residue	residue	NN	O
at	at	IN	O
the	the	DT	O
catalytic	catalytic	JJ	O
domain	domain	NN	O
.	.	.	O

Its	-PRON-	PRP$	O
backbone	backbone	NN	O
lines	line	VBZ	O
up	up	RP	O
at	at	IN	O
the	the	DT	O
entrance	entrance	NN	O
of	of	IN	O
the	the	DT	O
active	active	JJ	O
site	site	NN	O
.	.	.	O

Therefore	therefore	RB	O
,	,	,	O
its	-PRON-	PRP$	O
fluorescence	fluorescence	NN	O
change	change	NN	O
can	can	MD	O
reflect	reflect	VB	O
environmental	environmental	JJ	O
variation	variation	NN	O
of	of	IN	O
the	the	DT	O
active	active	JJ	O
site	site	NN	O
.	.	.	O

The	the	DT	O
catalytic	catalytic	JJ	O
domain	domain	NN	O
of	of	IN	O
SARS	SARS	NNP	O
-	-	HYPH	O
CoV	CoV	NNP	O
3CLpro	3clpro	CD	O
used	use	VBN	O
in	in	IN	O
this	this	DT	O
study	study	NN	O
displays	display	VBZ	O
a	a	DT	O
fluorescence	fluorescence	NN	O
peak	peak	NN	O
at	at	IN	O
340ânm	340ânm	CD	O
after	after	IN	O
the	the	DT	O
tryptophan	tryptophan	NNP	O
excitation	excitation	NN	O
wavelength	wavelength	NN	O
of	of	IN	O
290ânm	290ânm	CD	O
.	.	.	O

We	-PRON-	PRP	O
monitored	monitor	VBD	O
the	the	DT	O
change	change	NN	O
of	of	IN	O
the	the	DT	O
fluorescence	fluorescence	NN	O
intensities	intensity	NNS	O
depending	depend	VBG	O
on	on	IN	O
the	the	DT	O
presence	presence	NN	O
or	or	CC	O
absence	absence	NN	O
of	of	IN	O
all	all	DT	O
flavonoids	flavonoid	NNS	O
.	.	.	O

Since	since	IN	O
each	each	DT	O
compound	compound	NN	O
in	in	IN	O
the	the	DT	O
flavonoid	flavonoid	JJ	O
library	library	NN	O
was	be	VBD	O
almost	almost	RB	O
non	non	JJ	O
-	-	JJ	O
fluorescent	fluorescent	JJ	O
under	under	IN	O
the	the	DT	O
experiment	experiment	NN	O
condition	condition	NN	O
,	,	,	O
a	a	DT	O
change	change	NN	O
of	of	IN	O
fluorescence	fluorescence	NN	O
intensity	intensity	NN	O
reflects	reflect	VBZ	O
interactions	interaction	NNS	O
between	between	IN	O
the	the	DT	O
catalytic	catalytic	JJ	O
domain	domain	NN	O
and	and	CC	O
chemicals	chemical	NNS	O
.	.	.	O

Intriguingly	intriguingly	RB	O
,	,	,	O
the	the	DT	O
three	three	CD	O
inhibitory	inhibitory	JJ	O
compounds	compound	NNS	O
obviously	obviously	RB	O
reduced	reduce	VBD	O
the	the	DT	O
fluorescence	fluorescence	NN	O
intensity	intensity	NN	O
of	of	IN	O
the	the	DT	O
catalytic	catalytic	JJ	O
domain	domain	NN	O
compared	compare	VBN	O
with	with	IN	O
others	other	NNS	O
.	.	.	O

The	the	DT	O
decreased	decrease	VBN	O
emission	emission	NN	O
intensity	intensity	NN	O
confirmed	confirm	VBD	O
the	the	DT	O
complex	complex	JJ	O
formation	formation	NN	O
between	between	IN	O
the	the	DT	O
catalytic	catalytic	JJ	O
domain	domain	NN	O
and	and	CC	O
inhibitory	inhibitory	JJ	O
compounds	compound	NNS	O
.	.	.	O

Fluorescence	fluorescence	NN	O
quenching	quenching	NN	O
spectra	spectra	NN	O
of	of	IN	O
SARS	SARS	NNP	O
-	-	HYPH	O
CoV	CoV	NNP	O
3CLpro	3clpro	CD	O
.	.	.	O

A	a	DT	O
solution	solution	NN	O
containing	contain	VBG	O
1âÎ¼M	1âî¼m	CD	O
SARS	SARS	NNP	O
-	-	HYPH	O
CoV	CoV	NNP	O
3CLpro	3clpro	CD	O
showed	show	VBD	O
a	a	DT	O
strong	strong	JJ	O
fluorescence	fluorescence	NN	O
emission	emission	NN	O
with	with	IN	O
a	a	DT	O
peak	peak	NN	O
at	at	IN	O
340ânm	340ânm	CD	O
at	at	IN	O
the	the	DT	O
excitation	excitation	NN	O
wavelength	wavelength	NN	O
of	of	IN	O
290ânm	290ânm	CD	O
.	.	.	O

After	after	IN	O
adding	add	VBG	O
40âÎ¼M	40âî¼m	CD	O
each	each	DT	O
inhibitory	inhibitory	NN	O
compound	compound	NN	O
such	such	JJ	O
as	as	IN	O
herbacetin	herbacetin	NNP	O
,	,	,	O
rhoifolin	rhoifolin	NNP	O
and	and	CC	O
pectolinarin	pectolinarin	NNP	O
,	,	,	O
fluorescence	fluorescence	NN	O
quenching	quench	VBG	O
spectra	spectra	NNP	O
were	be	VBD	O
obtained	obtain	VBN	O
.	.	.	O

In	in	IN	O
order	order	NN	O
to	to	TO	O
deduce	deduce	VB	O
the	the	DT	O
binding	bind	VBG	O
modes	mode	NNS	O
of	of	IN	O
the	the	DT	O
inhibitory	inhibitory	JJ	O
flavonoids	flavonoid	NNS	O
in	in	IN	O
the	the	DT	O
molecular	molecular	JJ	O
level	level	NN	O
,	,	,	O
an	an	DT	O
in	in	IN	O
-	-	HYPH	O
depth	depth	NN	O
theoretical	theoretical	JJ	O
investigation	investigation	NN	O
through	through	IN	O
an	an	DT	O
induced	induce	VBN	O
-	-	HYPH	O
fit	fit	NN	O
docking	docking	NN	O
study	study	NN	O
was	be	VBD	O
carried	carry	VBN	O
out	out	RP	O
.	.	.	O

The	the	DT	O
interactions	interaction	NNS	O
between	between	IN	O
SARS	SARS	NNP	O
-	-	HYPH	O
CoV	CoV	NNP	O
3CLpro	3clpro	CD	O
and	and	CC	O
three	three	CD	O
inhibitory	inhibitory	JJ	O
flavonoids	flavonoid	NNS	O
were	be	VBD	O
analysed	analyse	VBN	O
to	to	TO	O
predict	predict	VB	O
their	-PRON-	PRP$	O
binding	bind	VBG	O
affinities	affinity	NNS	O
.	.	.	O

Top	top	JJ	O
-	-	HYPH	O
ranked	rank	VBN	O
structures	structure	NNS	O
from	from	IN	O
the	the	DT	O
induced	induce	VBN	O
-	-	HYPH	O
fit	fit	NN	O
docking	docking	NN	O
results	result	NNS	O
for	for	IN	O
herbacetin	herbacetin	NNP	O
â9.263	â9.263	NNP	O
,	,	,	O
rhoifolin	rhoifolin	NN	O
â9.565	â9.565	NNP	O
and	and	CC	O
pectolinarin	pectolinarin	NNP	O
â8.054	â8.054	NNP	O
were	be	VBD	O
selected	select	VBN	O
and	and	CC	O
hypothesised	hypothesise	VBN	O
to	to	TO	O
be	be	VB	O
biological	biological	JJ	O
complexes	complex	NNS	O
.	.	.	O

To	to	TO	O
find	find	VB	O
reasonable	reasonable	JJ	O
structural	structural	JJ	O
factors	factor	NNS	O
endowing	endow	VBG	O
the	the	DT	O
good	good	JJ	O
affinity	affinity	NN	O
of	of	IN	O
herbacetin	herbacetin	NNP	O
,	,	,	O
the	the	DT	O
poses	pose	NNS	O
of	of	IN	O
kaempferol	kaempferol	NNP	O
â8.526	â8.526	NNP	O
and	and	CC	O
morin	morin	NNP	O
â8.930	â8.930	NNP	O
,	,	,	O
two	two	CD	O
closest	close	JJS	O
homologues	homologue	NNS	O
,	,	,	O
were	be	VBD	O
also	also	RB	O
calculated	calculate	VBN	O
and	and	CC	O
compared	compare	VBN	O
.	.	.	O

The	the	DT	O
predicted	predict	VBN	O
complex	complex	JJ	O
structures	structure	NNS	O
and	and	CC	O
2D	2D	VBN	O
schematic	schematic	JJ	O
representations	representation	NNS	O
of	of	IN	O
them	-PRON-	PRP	O
are	be	VBP	O
illustrated	illustrate	VBN	O
in	in	IN	O
Figure	Figure	NNP	O
4	4	CD	O
.	.	.	O

Predicted	predict	VBN	O
complexes	complex	NNS	O
of	of	IN	O
flavonoids	flavonoid	NNS	O
in	in	IN	O
the	the	DT	O
catalytic	catalytic	JJ	O
site	site	NN	O
of	of	IN	O
SARS	SARS	NNP	O
-	-	HYPH	O
CoV	CoV	NNP	O
3CLpro	3clpro	CD	O
.	.	.	O

Docking	docking	NN	O
poses	pose	NNS	O
of	of	IN	O
herbacetin	herbacetin	NNP	O
,	,	,	O
kaempferol	kaempferol	NNP	O
and	and	CC	O
morin	morin	NNP	O
and	and	CC	O
rhoifolin	rhoifolin	NNP	O
and	and	CC	O
pectolinarin	pectolinarin	NNP	O
were	be	VBD	O
depicted	depict	VBN	O
on	on	IN	O
the	the	DT	O
electrostatic	electrostatic	JJ	O
surface	surface	NN	O
potential	potential	NN	O
of	of	IN	O
SARS	SARS	NNP	O
-	-	HYPH	O
CoV	CoV	NNP	O
3CLpro	3clpro	CD	O
.	.	.	O

Flavonoids	flavonoid	NNS	O
were	be	VBD	O
predicted	predict	VBN	O
to	to	TO	O
occupy	occupy	VB	O
the	the	DT	O
active	active	JJ	O
site	site	NN	O
of	of	IN	O
SARS	SARS	NNP	O
-	-	HYPH	O
CoV	CoV	NNP	O
3CLpro	3clpro	CD	O
.	.	.	O

The	the	DT	O
2D	2d	JJ	O
schematic	schematic	JJ	O
representations	representation	NNS	O
of	of	IN	O
the	the	DT	O
interactions	interaction	NNS	O
of	of	IN	O
five	five	CD	O
flavonoids	flavonoid	NNS	O
were	be	VBD	O
also	also	RB	O
drawn	draw	VBN	O
.	.	.	O

Figures	figure	NNS	O
were	be	VBD	O
created	create	VBN	O
with	with	IN	O
Maestro	Maestro	NNP	O
v11.5.011	v11.5.011	NNP	O
.	.	.	O

S1	S1	NNP	O
represents	represent	VBZ	O
the	the	DT	O
polar	polar	JJ	O
S1	s1	NN	O
site	site	NN	O
of	of	IN	O
SARS	SARS	NNP	O
-	-	HYPH	O
CoV	CoV	NNP	O
3CLpro	3clpro	CD	O
,	,	,	O
S2	s2	NN	O
for	for	IN	O
the	the	DT	O
hydrophobic	hydrophobic	NNP	O
S2	s2	NN	O
site	site	NN	O
,	,	,	O
and	and	CC	O
the	the	DT	O
S3â²	S3â²	NNP	O
site	site	NN	O
with	with	IN	O
no	no	DT	O
strong	strong	JJ	O
tendency	tendency	NN	O
.	.	.	O

The	the	DT	O
pink	pink	JJ	O
arrows	arrow	NNS	O
represent	represent	VBP	O
hydrogen	hydrogen	NN	O
bond	bond	NN	O
interaction	interaction	NN	O
.	.	.	O

Flavonoids	flavonoid	NNS	O
are	be	VBP	O
an	an	DT	O
important	important	JJ	O
kind	kind	NN	O
of	of	IN	O
natural	natural	JJ	O
products	product	NNS	O
.	.	.	O

In	in	IN	O
particular	particular	JJ	O
,	,	,	O
they	-PRON-	PRP	O
belong	belong	VBP	O
to	to	IN	O
a	a	DT	O
type	type	NN	O
of	of	IN	O
plant	plant	NN	O
secondary	secondary	JJ	O
metabolites	metabolite	NNS	O
with	with	IN	O
a	a	DT	O
polyphenolic	polyphenolic	JJ	O
structure	structure	NN	O
widely	widely	RB	O
found	find	VBN	O
in	in	IN	O
fruits	fruit	NNS	O
and	and	CC	O
vegetables	vegetable	NNS	O
.	.	.	O

They	-PRON-	PRP	O
have	have	VBP	O
miscellaneous	miscellaneous	JJ	O
reciprocal	reciprocal	JJ	O
biochemical	biochemical	JJ	O
and	and	CC	O
antioxidant	antioxidant	JJ	O
effects	effect	NNS	O
associated	associate	VBN	O
with	with	IN	O
various	various	JJ	O
diseases	disease	NNS	O
such	such	JJ	O
as	as	IN	O
cancer	cancer	NN	O
,	,	,	O
Alzheimer	Alzheimer	NNP	O
's	's	POS	O
disease	disease	NN	O
and	and	CC	O
atherosclerosis	atherosclerosis	NN	B
.	.	.	O

It	-PRON-	PRP	O
is	be	VBZ	O
due	due	JJ	O
to	to	IN	O
antioxidants	antioxidant	NNS	O
,	,	,	O
anti	anti	JJ	O
-	-	JJ	O
inflammatory	inflammatory	JJ	O
,	,	,	O
anti	anti	JJ	O
-	-	JJ	O
mutagens	mutagens	JJ	O
and	and	CC	O
anti	anti	JJ	O
-	-	JJ	O
cancer	cancer	JJ	O
-	-	HYPH	O
causing	cause	VBG	O
properties	property	NNS	O
combined	combine	VBN	O
with	with	IN	O
the	the	DT	O
ability	ability	NN	O
to	to	TO	O
control	control	VB	O
major	major	JJ	O
cell	cell	NN	O
enzyme	enzyme	NNS	O
functions	function	NNS	B
.	.	.	O

Intriguingly	intriguingly	RB	O
,	,	,	O
some	some	DT	O
flavonoids	flavonoid	NNS	O
also	also	RB	O
have	have	VBP	O
antiviral	antiviral	JJ	O
activity	activity	NN	B
.	.	.	O

Specifically	specifically	RB	O
,	,	,	O
apigenin	apigenin	NN	O
,	,	,	O
luteolin	luteolin	NNP	O
,	,	,	O
quercetin	quercetin	UH	O
,	,	,	O
amentoflavone	amentoflavone	NN	B
,	,	,	O
quercetin	quercetin	NNP	O
,	,	,	O
daidzein	daidzein	NNP	O
,	,	,	O
puerarin	puerarin	NNP	O
,	,	,	O
epigallocatechin	epigallocatechin	NNP	O
,	,	,	O
epigallocatechin	epigallocatechin	NNP	O
gallate	gallate	NNP	O
,	,	,	O
gallocatechin	gallocatechin	NN	O
gallate	gallate	JJ	B
and	and	CC	O
kaempferol	kaempferol	VB	B
were	be	VBD	O
reported	report	VBN	O
to	to	TO	O
inhibit	inhibit	VB	O
the	the	DT	O
proteolytic	proteolytic	JJ	O
activity	activity	NN	O
of	of	IN	O
SARS	SARS	NNP	O
-	-	HYPH	O
CoV	CoV	NNP	O
3CLpro	3clpro	CD	O
.	.	.	O

Therefore	therefore	RB	O
,	,	,	O
the	the	DT	O
antiviral	antiviral	JJ	O
effect	effect	NN	O
is	be	VBZ	O
presumed	presume	VBN	O
to	to	TO	O
be	be	VB	O
directly	directly	RB	O
linked	link	VBN	O
to	to	TO	O
suppress	suppress	VB	O
the	the	DT	O
activity	activity	NN	O
of	of	IN	O
SARS	SARS	NNP	O
-	-	HYPH	O
CoV	CoV	NNP	O
3CLpro	3clpro	CD	O
in	in	IN	O
some	some	DT	O
cases	case	NNS	O
.	.	.	O

However	however	RB	O
,	,	,	O
the	the	DT	O
systematic	systematic	JJ	O
analysis	analysis	NN	O
using	use	VBG	O
various	various	JJ	O
scaffolds	scaffold	NNS	O
of	of	IN	O
flavonoids	flavonoid	NNS	O
was	be	VBD	O
not	not	RB	O
reported	report	VBN	O
.	.	.	O

In	in	IN	O
order	order	NN	O
to	to	TO	O
find	find	VB	O
the	the	DT	O
best	good	JJS	O
scaffold	scaffold	NN	O
to	to	TO	O
inhibit	inhibit	VB	O
the	the	DT	O
function	function	NN	O
of	of	IN	O
SARS	SARS	NNP	O
-	-	HYPH	O
CoV	CoV	NNP	O
3CLpro	3clpro	CD	O
,	,	,	O
an	an	DT	O
assay	assay	NN	O
with	with	IN	O
various	various	JJ	O
flavonoid	flavonoid	JJ	O
derivatives	derivative	NNS	O
classified	classify	VBN	O
in	in	IN	O
10	10	CD	O
scaffolds	scaffold	NNS	O
was	be	VBD	O
built	build	VBN	O
and	and	CC	O
performed	perform	VBN	O
.	.	.	O

Among	among	IN	O
them	-PRON-	PRP	O
,	,	,	O
the	the	DT	O
best	good	JJS	O
compounds	compound	NNS	O
were	be	VBD	O
one	one	CD	O
flavonol	flavonol	NN	O
,	,	,	O
herbacetin	herbacetin	NNP	O
and	and	CC	O
two	two	CD	O
flavones	flavone	NNS	O
,	,	,	O
rhoifolin	rhoifolin	NN	O
and	and	CC	O
pectolinarin	pectolinarin	NN	O
.	.	.	O

In	in	IN	O
the	the	DT	O
current	current	JJ	O
assay	assay	NN	O
method	method	NN	O
including	include	VBG	O
0.01	0.01	CD	O
%	%	NN	O
Triton	Triton	NNP	O
X-100	X-100	NNP	O
,	,	,	O
the	the	DT	O
three	three	CD	O
flavonoids	flavonoid	NNS	O
showed	show	VBD	O
the	the	DT	O
better	well	JJR	O
inhibitory	inhibitory	JJ	O
activity	activity	NN	O
than	than	IN	O
the	the	DT	O
previously	previously	RB	O
reported	report	VBN	O
flavonoids	flavonoid	NNS	O
as	as	IN	O
mentioned	mention	VBN	O
above	above	IN	B
.	.	.	O

The	the	DT	O
aggregating	aggregating	JJ	O
tendency	tendency	NN	O
of	of	IN	O
flavonoids	flavonoid	NNS	O
frequently	frequently	RB	O
leads	lead	VBZ	O
to	to	TO	O
obtain	obtain	VB	O
false	false	JJ	O
bioassay	bioassay	NN	O
results	result	NNS	O
and	and	CC	O
can	can	MD	O
be	be	VB	O
avoided	avoid	VBN	O
by	by	IN	O
adding	add	VBG	O
0.01	0.01	CD	O
%	%	NN	O
Triton	Triton	NNP	O
X-100	X-100	NNP	B
.	.	.	O

It	-PRON-	PRP	O
is	be	VBZ	O
worthwhile	worthwhile	JJ	O
to	to	TO	O
note	note	VB	O
that	that	IN	O
amentoflavone	amentoflavone	NN	O
,	,	,	O
the	the	DT	O
most	most	RBS	O
effective	effective	JJ	O
flavonoid	flavonoid	NN	O
inhibiting	inhibit	VBG	O
SARS	SARS	NNP	O
-	-	HYPH	O
CoV	CoV	NNP	O
3CLpro	3clpro	CD	B
,	,	,	O
did	do	VBD	O
not	not	RB	O
effectively	effectively	RB	O
function	function	VB	O
in	in	IN	O
the	the	DT	O
presence	presence	NN	O
of	of	IN	O
0.01	0.01	CD	O
%	%	NN	O
Triton	Triton	NNP	O
X-100	X-100	NNP	O
.	.	.	O

The	the	DT	O
effect	effect	NN	O
of	of	IN	O
Triton	Triton	NNP	O
X-100	X-100	NNP	O
on	on	IN	O
flavonoids	flavonoid	NNS	O
.	.	.	O

Each	each	DT	O
of	of	IN	O
two	two	CD	O
bars	bar	NNS	O
represents	represent	VBZ	O
the	the	DT	O
inhibitory	inhibitory	JJ	O
activity	activity	NN	O
of	of	IN	O
compounds	compound	NNS	O
w	w	NNP	O
/	/	SYM	O
wt	wt	NNP	O
0.01	0.01	CD	O
%	%	NN	O
Triton	Triton	NNP	O
X-100	X-100	NNP	O
.	.	.	O

The	the	DT	O
first	first	JJ	O
bar	bar	NN	O
represents	represent	VBZ	O
the	the	DT	O
control	control	NN	O
.	.	.	O

Inhibitory	Inhibitory	NNP	O
compounds	compound	NNS	O
were	be	VBD	O
used	use	VBN	O
at	at	IN	O
40âÎ¼M	40âî¼m	CD	O
concentration	concentration	NN	O
.	.	.	O

Each	each	DT	O
bar	bar	NN	O
is	be	VBZ	O
expressed	express	VBN	O
as	as	IN	O
the	the	DT	O
meanâÂ±âstandard	meanâÂ±âstandard	NNP	O
error	error	NN	O
of	of	IN	O
the	the	DT	O
mean	mean	NN	O
nâ=â3	nâ=â3	NNP	O
.	.	.	O

RFU	RFU	NNP	O
:	:	:	O
Relative	Relative	NNP	O
Fluorescence	Fluorescence	NNP	O
Units	Units	NNPS	O
.	.	.	O

To	to	TO	O
elucidate	elucidate	VB	O
the	the	DT	O
relationship	relationship	NN	O
between	between	IN	O
binding	bind	VBG	O
mode	mode	NN	O
and	and	CC	O
binding	bind	VBG	O
affinity	affinity	NN	O
,	,	,	O
a	a	DT	O
docking	docking	NN	O
study	study	NN	O
for	for	IN	O
herbacetin	herbacetin	NNP	O
homologues	homologues	NNP	O
,	,	,	O
kaempferol	kaempferol	NNP	O
and	and	CC	O
morin	morin	NNP	O
,	,	,	O
were	be	VBD	O
also	also	RB	O
performed	perform	VBN	O
.	.	.	O

The	the	DT	O
glide	glide	NN	O
scores	score	NNS	O
of	of	IN	O
three	three	CD	O
compounds	compound	NNS	O
were	be	VBD	O
â9.263	â9.263	CD	O
,	,	,	O
â8.526	â8.526	NNP	O
and	and	CC	O
â8.930	â8.930	NNP	O
,	,	,	O
respectively	respectively	RB	O
.	.	.	O

The	the	DT	O
tendency	tendency	NN	O
of	of	IN	O
the	the	DT	O
glide	glide	NN	O
scores	score	NNS	O
is	be	VBZ	O
matched	match	VBN	O
with	with	IN	O
the	the	DT	O
binding	bind	VBG	O
affinity	affinity	NN	O
of	of	IN	O
the	the	DT	O
compounds	compound	NNS	O
.	.	.	O

The	the	DT	O
comparison	comparison	NN	O
of	of	IN	O
the	the	DT	O
predicted	predict	VBN	O
binding	bind	VBG	O
modes	mode	NNS	O
of	of	IN	O
three	three	CD	O
complex	complex	JJ	O
structures	structure	NNS	O
showed	show	VBD	O
critical	critical	JJ	O
factors	factor	NNS	O
governing	govern	VBG	O
their	-PRON-	PRP$	O
binding	bind	VBG	O
affinity	affinity	NN	O
.	.	.	O

In	in	IN	O
common	common	JJ	O
,	,	,	O
they	-PRON-	PRP	O
share	share	VBP	O
the	the	DT	O
kaempferol	kaempferol	NNP	O
motif	motif	NN	O
.	.	.	O

As	as	IN	O
shown	show	VBN	O
in	in	IN	O
Figure	Figure	NNP	O
4	4	CD	O
,	,	,	O
the	the	DT	O
phenyl	phenyl	NNP	O
moiety	moiety	NN	O
of	of	IN	O
kaempferol	kaempferol	NNP	O
occupies	occupy	VBZ	O
the	the	DT	O
S1	S1	NNS	O
site	site	NN	O
of	of	IN	O
SARS	SARS	NNP	O
-	-	HYPH	O
CoV	CoV	NNP	O
through	through	IN	O
a	a	DT	O
hydrogen	hydrogen	NN	O
bond	bond	NN	O
with	with	IN	O
Glu166	glu166	CD	O
.	.	.	O

In	in	IN	O
contrast	contrast	NN	O
,	,	,	O
the	the	DT	O
chromen-4-one	chromen-4-one	NNP	O
scaffold	scaffold	NN	O
of	of	IN	O
kaempferol	kaempferol	NN	O
locates	locate	NNS	O
in	in	IN	O
the	the	DT	O
S2	s2	NN	O
site	site	NN	O
.	.	.	O

In	in	IN	O
herbacetin	herbacetin	NNP	O
,	,	,	O
total	total	NN	O
of	of	IN	O
four	four	CD	O
hydrogen	hydrogen	NN	O
bonds	bond	NNS	O
are	be	VBP	O
formed	form	VBN	O
within	within	IN	O
a	a	DT	O
distance	distance	NN	O
of	of	IN	O
2.33âÃ	2.33âã	CD	O
in	in	IN	O
the	the	DT	O
S2	s2	NN	O
site	site	NN	O
.	.	.	O

Especially	especially	RB	O
,	,	,	O
the	the	DT	O
major	major	JJ	O
binding	bind	VBG	O
force	force	NN	O
was	be	VBD	O
driven	drive	VBN	O
by	by	IN	O
the	the	DT	O
presence	presence	NN	O
of	of	IN	O
the	the	DT	O
additional	additional	JJ	O
8-hydroxyl	8-hydroxyl	CD	O
group	group	NN	O
which	which	WDT	O
plays	play	VBZ	O
a	a	DT	O
critical	critical	JJ	O
role	role	NN	O
in	in	IN	O
binding	bind	VBG	O
with	with	IN	O
Glu166	glu166	CD	O
and	and	CC	O
Gln189	gln189	CD	O
.	.	.	O

These	these	DT	O
bindings	binding	NNS	O
are	be	VBP	O
predicted	predict	VBN	O
to	to	TO	O
confer	confer	VB	O
a	a	DT	O
good	good	JJ	O
glide	glide	NN	O
score	score	NN	O
of	of	IN	O
herbacetin	herbacetin	NNP	O
.	.	.	O

In	in	IN	O
contrast	contrast	NN	O
,	,	,	O
the	the	DT	O
binding	bind	VBG	O
modes	mode	NNS	O
of	of	IN	O
morin	morin	NNP	O
and	and	CC	O
kaemperol	kaemperol	NNP	O
become	become	VBP	O
different	different	JJ	O
due	due	IN	O
to	to	IN	O
the	the	DT	O
absence	absence	NN	O
of	of	IN	O
above	above	IN	O
two	two	CD	O
hydrogen	hydrogen	NN	O
bonds	bond	NNS	O
due	due	JJ	O
the	the	DT	O
lack	lack	NN	O
of	of	IN	O
the	the	DT	O
8-hydroxyl	8-hydroxyl	CD	O
group	group	NN	O
.	.	.	O

The	the	DT	O
absence	absence	NN	O
also	also	RB	O
induces	induce	VBZ	O
the	the	DT	O
change	change	NN	O
nullifying	nullify	VBG	O
the	the	DT	O
hydrogen	hydrogen	NN	O
bond	bond	NN	O
formed	form	VBN	O
by	by	IN	O
the	the	DT	O
5-hydroxyl	5-hydroxyl	CD	O
group	group	NN	O
of	of	IN	O
the	the	DT	O
chromen-4-one	chromen-4-one	NNP	O
scaffold	scaffold	NN	O
with	with	IN	O
Asp187	asp187	CD	O
observed	observe	VBN	O
in	in	IN	O
herbacetin	herbacetin	NNP	O
.	.	.	O

Though	though	IN	O
there	there	EX	O
is	be	VBZ	O
a	a	DT	O
new	new	JJ	O
hydrogen	hydrogen	NN	O
bond	bond	NN	O
formed	form	VBN	O
through	through	IN	O
the	the	DT	O
3-hydroxyl	3-hydroxyl	CD	O
group	group	NN	O
,	,	,	O
it	-PRON-	PRP	O
may	may	MD	O
not	not	RB	O
enough	enough	RB	O
to	to	TO	O
overcome	overcome	VB	O
the	the	DT	O
loss	loss	NN	O
of	of	IN	O
binding	bind	VBG	O
capacity	capacity	NN	O
induced	induce	VBN	O
by	by	IN	O
the	the	DT	O
8-hydroxyl	8-hydroxyl	CD	O
group	group	NN	O
.	.	.	O

This	this	DT	O
survey	survey	NN	O
shows	show	VBZ	O
the	the	DT	O
importance	importance	NN	O
of	of	IN	O
the	the	DT	O
8-hydroxyl	8-hydroxyl	CD	O
group	group	NN	O
at	at	IN	O
the	the	DT	O
strong	strong	JJ	O
binding	binding	NN	O
affinity	affinity	NN	O
of	of	IN	O
herbacetin	herbacetin	NNP	O
.	.	.	O

The	the	DT	O
glide	glide	NN	O
scores	score	NNS	O
of	of	IN	O
rhoifolin	rhoifolin	NN	O
and	and	CC	O
pectolinarin	pectolinarin	NNP	O
were	be	VBD	O
â9.565	â9.565	NNP	O
and	and	CC	O
â8.054	â8.054	NNP	O
,	,	,	O
respectively	respectively	RB	O
.	.	.	O

They	-PRON-	PRP	O
belong	belong	VBP	O
to	to	IN	O
the	the	DT	O
flavone	flavone	JJ	O
family	family	NN	O
.	.	.	O

Interestingly	interestingly	RB	O
,	,	,	O
their	-PRON-	PRP$	O
binding	bind	VBG	O
modes	mode	NNS	O
are	be	VBP	O
different	different	JJ	O
from	from	IN	O
those	those	DT	O
of	of	IN	O
the	the	DT	O
above	above	JJ	O
three	three	CD	O
flavonols	flavonol	NNS	O
.	.	.	O

Rhoifolin	Rhoifolin	NNP	O
and	and	CC	O
pectolinarin	pectolinarin	NNP	O
possess	possess	VBP	O
Î±-l	Î±-l	NNP	O
-	-	HYPH	O
rhamnopyranosyl	rhamnopyranosyl	VBN	O
Î²-d	Î²-d	NNP	O
-	-	HYPH	O
glucopyranoside	glucopyranoside	NNP	O
and	and	CC	O
l	l	NN	O
-	-	HYPH	O
mannopyranosyl	mannopyranosyl	NN	O
Î²-d	Î²-d	NNP	O
-	-	HYPH	O
glucopyranoside	glucopyranoside	NNP	O
,	,	,	O
respectively	respectively	RB	O
.	.	.	O

The	the	DT	O
additional	additional	JJ	O
bulky	bulky	JJ	O
carbohydrate	carbohydrate	NN	O
groups	group	NNS	O
are	be	VBP	O
attached	attach	VBN	O
to	to	IN	O
7-position	7-position	CD	O
of	of	IN	O
the	the	DT	O
chromen-4-one	chromen-4-one	NNP	O
scaffold	scaffold	NN	O
.	.	.	O

As	as	IN	O
a	a	DT	O
result	result	NN	O
,	,	,	O
the	the	DT	O
hydrogen	hydrogen	NN	O
bond	bond	NN	O
formed	form	VBN	O
between	between	IN	O
the	the	DT	O
7-hydroxyl	7-hydroxyl	CD	O
group	group	NN	O
and	and	CC	O
the	the	DT	O
backbone	backbone	NN	O
of	of	IN	O
Ile188	ile188	CD	O
was	be	VBD	O
abolished	abolish	VBN	O
.	.	.	O

In	in	IN	O
addition	addition	NN	O
,	,	,	O
the	the	DT	O
bulky	bulky	JJ	O
groups	group	NNS	O
require	require	VBP	O
a	a	DT	O
large	large	JJ	O
space	space	NN	O
to	to	TO	O
reside	reside	VB	O
in	in	RP	O
.	.	.	O

Therefore	therefore	RB	O
,	,	,	O
these	these	DT	O
carbohydrate	carbohydrate	NN	O
groups	group	NNS	O
occupy	occupy	VBP	O
the	the	DT	O
S1	S1	NNS	O
and	and	CC	O
S2	s2	NN	O
sites	site	NNS	O
and	and	CC	O
the	the	DT	O
chromen-4-one	chromen-4-one	NNP	O
moieties	moiety	NNS	O
locate	locate	VBP	O
in	in	IN	O
the	the	DT	O
S2	s2	NN	O
and	and	CC	O
S3â²	S3â²	NNP	O
sites	site	NNS	O
,	,	,	O
unlike	unlike	IN	O
the	the	DT	O
above	above	JJ	O
three	three	CD	O
flavonols	flavonol	NNS	O
.	.	.	O

The	the	DT	O
better	well	JJR	O
affinity	affinity	NN	O
of	of	IN	O
rhoifolin	rhoifolin	NN	O
may	may	MD	O
be	be	VB	O
due	due	IN	O
to	to	IN	O
orchestrated	orchestrate	VBN	O
binding	bind	VBG	O
through	through	IN	O
S1	S1	NNS	O
,	,	,	O
S2	S2	NNP	O
and	and	CC	O
S3	S3	NNP	O
'	'	''	O
sites	site	NNS	O
.	.	.	O

The	the	DT	O
assay	assay	NN	O
and	and	CC	O
docking	docking	NN	O
result	result	NN	O
indicates	indicate	VBZ	O
important	important	JJ	O
conclusions	conclusion	NNS	O
.	.	.	O

At	at	IN	O
first	first	RB	O
,	,	,	O
flavonoids	flavonoid	NNS	O
have	have	VBP	O
a	a	DT	O
wide	wide	JJ	O
range	range	NN	O
of	of	IN	O
binding	bind	VBG	O
affinity	affinity	NN	O
to	to	IN	O
SARS	SARS	NNP	O
-	-	HYPH	O
CoV	CoV	NNP	O
CLpro	CLpro	NNP	O
due	due	IN	O
to	to	IN	O
their	-PRON-	PRP$	O
hydrophobic	hydrophobic	JJ	O
aromatic	aromatic	JJ	O
rings	ring	NNS	O
and	and	CC	O
hydrophilic	hydrophilic	JJ	O
hydroxyl	hydroxyl	NN	O
groups	group	NNS	O
.	.	.	O

Second	second	RB	O
,	,	,	O
the	the	DT	O
presence	presence	NN	O
of	of	IN	O
carbohydrate	carbohydrate	NN	O
groups	group	NNS	O
influences	influence	VBZ	O
severely	severely	RB	O
to	to	IN	O
the	the	DT	O
binding	bind	VBG	O
affinity	affinity	NN	O
and	and	CC	O
mode	mode	NN	O
of	of	IN	O
the	the	DT	O
chromen-4-one	chromen-4-one	NNP	O
moiety	moiety	NN	O
.	.	.	O

Third	third	RB	O
,	,	,	O
Triton	Triton	NNP	O
X-100	X-100	NNP	O
is	be	VBZ	O
critical	critical	JJ	O
to	to	TO	O
reduce	reduce	VB	O
false	false	JJ	O
-	-	HYPH	O
positives	positive	NNS	O
and	and	CC	O
overestimates	overestimate	NNS	O
.	.	.	O

Based	base	VBN	O
on	on	IN	O
the	the	DT	O
result	result	NN	O
,	,	,	O
the	the	DT	O
strategy	strategy	NN	O
to	to	TO	O
cope	cope	VB	O
with	with	IN	O
SARS	SARS	NNP	O
targeting	target	VBG	O
SARS	SARS	NNP	O
-	-	HYPH	O
CoV	CoV	NNP	O
3CLpro	3clpro	CD	O
can	can	MD	O
be	be	VB	O
newly	newly	RB	O
designed	design	VBN	O
.	.	.	O

A	a	DT	O
further	further	JJ	O
study	study	NN	O
is	be	VBZ	O
going	go	VBG	O
on	on	RP	O
to	to	TO	O
make	make	VB	O
derivatives	derivative	NNS	O
which	which	WDT	O
lead	lead	VBP	O
to	to	IN	O
better	well	JJR	O
inhibitory	inhibitory	JJ	O
compounds	compound	NNS	O
based	base	VBN	O
on	on	IN	O
this	this	DT	O
study	study	NN	O
.	.	.	O

We	-PRON-	PRP	O
have	have	VBP	O
created	create	VBN	O
a	a	DT	O
library	library	NN	O
of	of	IN	O
flavonoids	flavonoid	NNS	O
to	to	TO	O
systematically	systematically	RB	O
investigate	investigate	VB	O
SARS	SARS	NNP	O
-	-	HYPH	O
CoV	CoV	NNP	O
3CLpro	3clpro	CD	O
inhibitory	inhibitory	JJ	O
compound	compound	NN	O
by	by	IN	O
a	a	DT	O
FRET	FRET	NNP	O
method	method	NN	O
.	.	.	O

Using	use	VBG	O
the	the	DT	O
library	library	NN	O
,	,	,	O
a	a	DT	O
number	number	NN	O
of	of	IN	O
flavonoids	flavonoid	NNS	O
with	with	IN	O
a	a	DT	O
wide	wide	JJ	O
range	range	NN	O
of	of	IN	O
inhibitory	inhibitory	JJ	O
activity	activity	NN	O
were	be	VBD	O
detected	detect	VBN	O
.	.	.	O

Intriguingly	intriguingly	RB	O
,	,	,	O
inhibitory	inhibitory	JJ	O
activities	activity	NNS	O
of	of	IN	O
some	some	DT	O
flavonoids	flavonoid	NNS	O
were	be	VBD	O
turned	turn	VBN	O
out	out	RP	O
to	to	TO	O
be	be	VB	O
artificial	artificial	JJ	O
when	when	WRB	O
triton	triton	NNP	O
X-100	X-100	NNP	O
was	be	VBD	O
treated	treat	VBN	O
.	.	.	O

Herbacetin	Herbacetin	NNP	O
,	,	,	O
rhoifolin	rhoifolin	NN	O
and	and	CC	O
pectolinarin	pectolinarin	NNP	O
were	be	VBD	O
the	the	DT	O
best	good	JJS	O
inhibitory	inhibitory	JJ	O
compounds	compound	NNS	O
against	against	IN	O
SARS	SARS	NNP	O
-	-	HYPH	O
CoV	CoV	NNP	O
3CLpro	3clpro	CD	O
in	in	IN	O
the	the	DT	O
flavonoid	flavonoid	JJ	O
library	library	NN	O
.	.	.	O

The	the	DT	O
binding	binding	NN	O
of	of	IN	O
the	the	DT	O
flavonoids	flavonoid	NNS	O
was	be	VBD	O
independently	independently	RB	O
demonstrated	demonstrate	VBN	O
by	by	IN	O
a	a	DT	O
tryptophan	tryptophan	NNP	O
-	-	HYPH	O
based	base	VBN	O
fluorescence	fluorescence	NN	O
method	method	NN	O
.	.	.	O

In	in	IN	O
order	order	NN	O
to	to	TO	O
predict	predict	VB	O
the	the	DT	O
flavonoid	flavonoid	NN	O
scaffolds	scaffold	NNS	O
needed	need	VBN	O
to	to	TO	O
interact	interact	VB	O
with	with	IN	O
the	the	DT	O
catalytic	catalytic	JJ	O
site	site	NN	O
of	of	IN	O
SARS	SARS	NNP	O
-	-	HYPH	O
CoV	CoV	NNP	O
3CLpro	3clpro	CD	O
,	,	,	O
an	an	DT	O
induced	induce	VBN	O
-	-	HYPH	O
fit	fit	NN	O
docking	docking	NN	O
study	study	NN	O
was	be	VBD	O
performed	perform	VBN	O
and	and	CC	O
analysed	analyse	VBN	O
.	.	.	O

The	the	DT	O
presence	presence	NN	O
of	of	IN	O
additional	additional	JJ	O
8-hydroxyl	8-hydroxyl	CD	O
group	group	NN	O
of	of	IN	O
herbacetin	herbacetin	NNP	O
was	be	VBD	O
expected	expect	VBN	O
to	to	TO	O
be	be	VB	O
critical	critical	JJ	O
to	to	TO	O
acquire	acquire	VB	O
its	-PRON-	PRP$	O
high	high	JJ	O
binding	binding	NN	O
affinity	affinity	NN	O
around	around	IN	O
the	the	DT	O
S1	S1	NNS	O
and	and	CC	O
S2	s2	NN	O
sites	site	NNS	O
.	.	.	O

The	the	DT	O
occupation	occupation	NN	O
of	of	IN	O
the	the	DT	O
S1	S1	NNS	O
and	and	CC	O
S2	s2	NN	O
sites	site	NNS	O
by	by	IN	O
carbohydrate	carbohydrate	NN	O
groups	group	NNS	O
of	of	IN	O
rhoifolin	rhoifolin	NN	O
and	and	CC	O
pectolinarin	pectolinarin	NNP	O
was	be	VBD	O
anticipated	anticipate	VBN	O
to	to	TO	O
be	be	VB	O
another	another	DT	O
way	way	NN	O
of	of	IN	O
getting	get	VBG	O
high	high	JJ	O
affinity	affinity	NN	O
to	to	IN	O
SARS	SARS	NNP	O
-	-	HYPH	O
CoV	CoV	NNP	O
3CLpro	3clpro	CD	O
in	in	IN	O
glycosylated	glycosylate	VBN	O
flavonoids	flavonoid	NNS	O
.	.	.	O

This	this	DT	O
study	study	NN	O
suggests	suggest	VBZ	O
that	that	IN	O
the	the	DT	O
biochemical	biochemical	JJ	O
assay	assay	NN	O
combined	combine	VBN	O
with	with	IN	O
the	the	DT	O
docking	docking	NN	O
prediction	prediction	NN	O
may	may	MD	O
be	be	VB	O
useful	useful	JJ	O
to	to	TO	O
develop	develop	VB	O
better	well	JJR	O
inhibitory	inhibitory	JJ	O
flavonoid	flavonoid	NN	O
derivatives	derivative	NNS	O
from	from	IN	O
various	various	JJ	O
flavonoid	flavonoid	NN	O
scaffolds	scaffold	NNS	O
.	.	.	O

